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ABSTRACT 
Enzymes, as highly efficient biocatalysts, have been researched extensively in both 
academia and industry because of their distinct advantages including high substrate 
specificity, high regio- and stereoselectivity, environmentally benign process, etc. Though 
enzyme catalysis has been scaled up for commercial processes in the pharmaceutical, food 
and beverage and detergent industries, technical barriers associated with enzyme 
implementation persist, i.e., low catalytic efficiency at non-natural environment, 
exhausting product separations, high cost of certain enzymes, etc. Moreover, currently 
most industrial enzymes are used in single-step reactions; however, multistep and 
multienzyme catalysis with optimal efficiency could greatly expand its potential for 
synthetic applications to achieve complex chemical transformations. In this dissertation, 
we use a polymer protein co-assembly strategy to construct core-shell nanoparticles to 
study multistep and multienzyme involved catalysis. An electrokinetics (EK) based 
microfluidic method has been explored to improve the polymer-protein(s) co-assembly and 
fabricate homogenous polymer-enzyme hybrid nanoparticles. A group of small molecules 
have been characterized as efficient P450 OleTSA enzyme activators providing novel 
strategies to enhance enzyme activity in situ. Finally, a surfactant assisted enzyme involved 
microemulsion formation via interfacial assembly has been studied.  
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Multienzyme based complex chemical transformations are common in biological 
processes ranging from protein synthesis to cellular metabolism. In nature, microorganisms 
have evolved features to maximize the catalytic efficiency of multienzyme based 
transformations by spatial organization, co-localization and microcompartmentation, 
through which proximity of multiple components of enzyme complex, mass transportation 
in the multistep catalysis can be sufficiently improved. Inspired by those biological 
systems, different strategies have been explored to improve multienzyme based catalysis 
including DNA scaffolds, protein scaffolds, polymeric particles assemblies, metal-organic 
frameworks, hydrogel encapsulation and cross-liked enzyme aggregates. While 
structurally and mechanistically diverse, the ultimate goal of these multiple enzyme 
assemblies is to accelerate reaction velocity and increase reaction efficiency. In this 
dissertation, protein(s) co-assembly strategies including protein-polymer co-assembly, 
protein-surfactant interfacial assembly have been explored to construct protein complexes 
in order to increase the enzymes’ activity. 
In Chapter 1, poly(4-vinylpyridine) polymer-arylamine N-oxygenase core shell 
nanoparticles (P4VP-CmlI) have been generated through co-assembly and studied to 
explore their potential use in a bio-catalytic platform. P4VP-CmlI shows excellent activity 
on two arylamine substrates, p-aminophenol (pAP) and p-aminobenzoic acid (pABA), 
using turnover methods that employed a surrogate redox system or a peroxide shunt. 
Products at different oxygenation stages can be generated with different substrates. In 
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comparison to the free enzyme, P4VP-CmlI hybrids have a significantly enhanced catalytic 
efficiency when using pyridine nucleotide (NADH) and appropriately poised redox 
mediators. The enhanced catalytic efficiency of the P4VP-CmlI assemblies is attributed to 
a more efficient electron delivery. 
In Chapter 2, we report an artificial enzyme cascade composed of glucose oxidase 
(GOx) and OleTSA from Staphylococcus aureus for efficient terminal alkene production. 
By adjusting the ratio of GOx to OleTSA, the GOx-based tandem catalysis shows 
significantly improved product yield compared to the H2O2 injection method. The co-
assembly of the GOx/OleTSA enzymes with a polymer, forming polymer-multienzymes 
nanoparticles, displays improved activity compared to the free enzyme. This two-fold 
strategy provides a simple and efficient system to transform a naturally abundant feedstock 
to industrially important chemicals. We attribute the enhanced effect of the co-assemblies 
origins from presence of large amount of OleTSA as H2O2 target on the nanoparticles 
surface as well as the closed proximity of the two enzymes after co-assembly. 
In Chapter 3, we explore an electrokinetics (EK) based microfluidic reactor with 
fast mixing to assemble functional proteins with polymers in an ethanol/water co-solvent 
system. The resultant NPs show significantly improved size distribution by comparison 
with the ones prepared using conventional bulk method, while the NPs size can be tuned 
by adjusting the mass ratio of polymer to protein. The functionalities of the assembled 
proteins are sustained upon the EK based microfluidic mixing, indicating the application 
potential of our method in the controlled assembly of different functional proteins. This 
work sheds light on the application of this EK-based microfluidic method for polymer 
enzyme(s) co-assembly. 
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In Chapter 4, we report the use of a class of small molecules to enhance OleTSA 
enzymatic activity in situ. Up to 6-fold enhanced activity has been obtained with small 
molecules synthesized in house. The small molecules and enzyme substrates co-locate at 
the enzyme active site simultaneously. We propose the origins of the enhancement are from 
the enzyme oxidation step and an H2O2 toxicity inhibiting effect. 
In Chapter 5, we use cytochrome P450 OleTSA as a model to study the interaction 
of surfactant and enzyme and its utilization for interfacial assembly. Both negative and 
positive surfactants can interact with OleTSA and facilitate emulsion formation via 
interfacial assembly. In particular, sodium dodecyl sulfate (SDS), a negative surfactant, 
has been identified as the optimal one to interact with OleTSA, which can form stable 
emulsions via the interfacial assembly. Biphasic enzymatic reactions have been conducted 
with fatty acids as substrates dissolved in hexane while the enzymes (GOx/OleTSA) located 
at the interface of organic/aqueous layer. With this system, the terminal alkene products 
can be enriched in organic layer during the catalysis, and the overall turnover rate is 
comparable to that in conversional single-phase reactions. 
Overall, we demonstrate that protein(s) co-assembly could be a viable approach to 
manipulate and improve the multistep and multienzyme based catalysis via different 
mechanisms. In Chapter 6, we provide some perspectives on future works to further 
understand the co-assembly process as well as how the process effects on enzyme catalysis, 
which will be beneficial to expand such strategies in enzyme engineering.
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CHAPTER 1 
ENHANCED ARYLAMINE N-OXYGENASE ACTIVITY OF POLYMER-ENZYME 
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1.1 INTRODUCTION 
Nitro- and nitrosoaromatic compounds1,2 are two important classes of chemicals 
which have been widely used as pharmaceuticals, pesticides, dyes, explosives and building 
blocks for synthesis and materials development.3–7 Although various synthetic methods 
have been developed over the decades,1,2,8 safety concerns, a lack of regioselectivity, and 
the resulting instability of the nitroso-compounds under the harsh preparatory conditions 
required often limit their preparation. As with other transformations, bio-catalytic 
platforms that can be carried out under mild reaction conditions have attracted significant 
attention for synthetic applications for these compounds.9–11 
Arylamine N-oxygenases catalyze the six-electron oxidation of aryl-amines to aryl-
nitro compounds via hydroxylamine and nitroso intermediates,12–16 providing a novel tool 
for stepwise Ar-NO and Ar-NO2 synthesis. Among these newly-characterized enzymes, 
CmlI is a representative arylamine N-oxygenase that utilizes a dinuclear-iron cofactor to 
catalyze the formation of the bioactive nitro-group of the antibiotic chloramphenicol 
(CAM) via oxidation of the arylamine precursor (NH2-CAM).
16  The mechanism and 
structure of CmlI reveal that the enzyme catalyzes N-oxygenation through successive 
reactions with an atypical (relative to other dinuclear oxygenases) and highly stable 
peroxo-diferric intermediate that is generated from reaction of the reduced diferrous protein 
with dioxygen.17–19 Interestingly, in addition to the final nitro-containing compound, 
nitroso- products can also accumulate in the enzymatic reaction with native substrate, NH2-
CAM.17 Thus, CmlI may be a promising biocatalyst for leveraging Ar-NO2 and/or Ar-NO 
synthesis if the oxygenation process can be controlled. 
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The use of N-oxygenases such as CmlI for synthetic applications is restricted by 
low catalytic efficiency. A native redox partner system that generates the diferrous form 
that subsequently reacts with O2 has yet to be identified. It has been reported that the 
activity of CmlI, and AurF, a closely related ortholog involved in aureothin biosynthesis, 
can be reconstituted using a surrogate redox system comprised of reduced pyridine 
nucleotide (NADH) and the redox-mediator phenazine methosulfate (PMS) (Scheme 
1.1).16,20 However, the uncoupled consumption of reducing equivalents likely resulting in 
the generation of damaging reactive oxygen species that may limit activity. An alternative 
method is to use H2O2 to bypass the need for reducing equivalents altogether and generate 
the reactive peroxo species directly (Scheme 1.1). This approach has been used to initiate 
turnover in various dinuclear-iron enzymes (e.g. AurF, soluble methane monoxygenase 
(sMMO) and toluene 4-monooxygenase (T4Mo))21–24 and variable levels of enzyme 
activity have been reported. For example, recent studies that have explored the shunt 
pathway in CmlI have shown that the addition of H2O2 to the diferric enzyme does not 
readily form the reactive peroxo-adduct that reacts with substrates.18 
 
Scheme 1.1 Illustration of the reconstitution of CmlI activity using NADH/PMS and 
dioxygen or via a peroxide shunt method. to generate a diferric-peroxide intermediate that 
reacts with arylamine substrates. 
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Polymer/enzyme hybrids have served as an alternative method for enzyme 
engineering. Upon polymer conjugation, many enzymes can exhibit improved stability, pH 
or temperature tolerance and catalytic efficiency with different mechanisms imparted by 
specific polymer structures.25–30 The construction and characterization of pyridine-grafted 
polymer-protein core shell nanoparticles (PPCS-NPs) has been systematically discussed in 
previous studies by our laboratory.31–36 The synthesis of PPCS-NPs is primarily 
entropically-driven, while the resultant nanoparticles are stabilized by synergistic 
interactions between polymers and proteins. The finely-balanced microenvironment can 
help to preserve enzyme conformation and function.36 With a robust one-step co-assembly 
protocol, the proteins bound on the surface of the PPCS-NPs was greater than 90% in 
comparison to the initial amount of the protein used. The PPCS-NPs were found typically 
stable in solution for about 1−2 weeks at room temperature and 4 weeks at 4 °C. During 
the process, no protein leaching has been observed.36 A broad range of functional proteins 
and protein cages have been co-assembled with specific polymers to form PPCS-NPs.36–38 
Moreover, the pyridine-containing polymers can exhibit a high electron affinity and 
favorable electron-donation properties from the pyridine unit.39–41 Collectively, these 
studies indicate that P4VP polymer assembly may be leveraged with CmlI to improve its 
performance as a biocatalyst. In the present study, we have generated P4VP-CmlI core-
shell nanoparticles through a co-assembly process and tested their catalytic activity with 
the arylamine substrates pAP and pABA. Interestingly, we observed that different 
intermediate products accumulate with these two substrates. We found that P4VP-CmlI 
showed significantly higher activity on both substrates than the free enzyme that is 
attributed to a more efficient electron delivery process due to proximity of enzymes and 
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cofactors. This step is rate-limiting in many classes of oxidoreductases42,43 and the 
identification of native redox-delivery systems can be a major bottleneck if the genes that 
encode them are located outside of the immediate genetic locus. As a result, the P4VP-
enzyme assembly method may be generally applicable to leverage oxidoreductase catalysis 
in a variety of synthetic platforms. 
1.2 EXPERIMENTAL SECTION 
1.2.1 MATERIALS 
P4VP (Mw 60000), p-aminophenol (pAP, >99.0%), flavin mononucleotide (FMN) 
and riboflavin were purchased from Sigma-Aldrich. Phenazine methosulfate (PMS, 
>98.0%), p-aminobenzoate (pABA, >99.0%) were purchased from TCI America. NADH 
sodium salt was purchased from EMD Millipore. Unless otherwise noted, all chemicals 
and solvents used were of analytical grade and were used as received from commercial 
sources. Water (18.2 MΩ) was obtained from Milli-Q system (Millipore). Unless otherwise 
noted, all buffers are 50 mM 3-(N-morpholino) propane sulfonic acid (MOPS), pH 7.4. 
1.2.2 HETEROLOGOUS EXPRESSION AND PURIFICATION OF CMLI  
The Streptomyces venezuelae CmlI gene, cloned into the pVP91A expression 
vector and characterized in previous studies,19 was used for protein expression. This vector 
contains an eight-histidine tag at the N-terminus to facilitate purification. Expression of 
CmlI was performed in E. coli BL21 (DE3) in LB medium in the presence of 100 µg/mL 
ampicillin. Cells were grown to an OD ~ 1.0 and induced with 150 µM IPTG and 50 µM 
FeCl3 at which point the temperature was lowered to 20 °C, and grown for an additional 
15 h. Cells were harvested by centrifugation for purification or stored at -80 °C for further 
use. The protein was purified using nickel-nitriloacetic acid (Ni-NTA) affinity 
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chromatography as described previously 19 and was subsequently dialyzed against 50 mM 
MOPS pH 7.4 buffer and stored at -80 °C until further use. Enzyme purity was assessed by 
SDS-PAGE and the iron-to-enzyme ratio was verified by the ferrozine assay (Figure S1).44 
1.2.3 SYNTHESIS OF P4VP-CMLI ASSEMBLIES 
A solution of P4VP in ethanol (7.5 mg·mL-1, 0.1 mL) was slowly added to a 
solution containing CmlI in 50 mM MOPS pH 7.4 (1.2 mg·mL-1, 0.9 mL) with stirring. 
After addition, the mixture was stirred for an additional 30 minutes. To study the influence 
of FMN reduction by NADH, the P4VP-CmlI assemblies were prepared with a similar 
procedure but with diluted P4VP (0.75 mg·mL-1, 0.1 mL) and CmlI enzyme (0.12 mg·mL-
1, 0.9 mL) in 50 mM MOPS pH 7.4. All the assembled samples were freshly prepared in 
the characterization and activity test. 
1.2.4 CHARACTERIZATION OF P4VP-CMLI ASSEMBLIES 
The P4VP-CmlI sample (20 µL) was centrifuged to collect the nanoparticles and 
resuspended with the same volume of water, dropped onto a stub and dried in the hood, 
then coated with a thin layer of gold film using a Denton Vacuum Desk II. The sputtered 
samples were fixed onto the sample holder and placed in the vacuum chamber of the 
microscope under low vacuum (1025 Torr) for imaging by the in-lens detector of Zeiss 
Ultraplus Thermal Field Emission Scanning Electron Microscope (FESEM). For TEM 
analysis, the sample was diluted 100 times by water, 20 μL diluted sample was dropped 
onto 300-mesh carbon-coated copper grids and dried. The grids were then stained with 20 
μL of uranyl acetate (2% w/v) for 5 minutes and observed with a Hitachi H-8000 electron 
microscope. The size distribution of P4VP-CmlI assemblies were measured with dynamic 
light scattering (DLS, Zetasizer Nano ZS, Malvern Instruments). The mean value for the 
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size based on the intensity, and the polydispersity index (PDI), a dimensionless width 
parameter based on the cumulant analysis, were detected.  
1.2.5 ACTIVITY ASSAY OF P4VP-CMLI ASSEMBLIES AND FREE CMLI 
The activity assay of both P4VP-CmlI and free CmlI were performed in a reaction 
volume of 100 μL. The final reaction mixture contained CmlI (20 μM), the substrate pAP 
or pABA (1 mM), PMS or FMN or riboflavin (12.5 - 125 μM), NADH (1 - 10 mM), and 
7% ethanol in MOPS buffer. Reactions were performed at room temperature (23 – 25°C) 
and were initiated by the addition of the substrate to the reaction mixture. The specific 
activity was calculated during the first 10 minutes. The PMS, FMN and riboflavin reagent 
were freshly prepared and kept dark until use. NADH and PMS or FMN or riboflavin were 
added immediately before each reaction to minimize any possible side reactions in the 
presence of oxygen.45 P4VP-CmlI and CmlI reactions were prepared and tested side-by-
side for an accurate comparison of activity. Reactions with pAP were measured by 
monitoring pNOP product formation at an absorbance of 405 nm with a Molecular Device 
SPECTRAMax plus 384 with a microplate reader using 0.33 cm path length. The activity 
assay with pABA was performed with the same procedure, the products were quantified 
by HPLC as described below. The assays were performed in at least triplicates and the 
averages were reported. 
1.2.6 PEROXIDE-SHUNT ASSAY 
Peroxide-shunt experiments were performed by the addition of H2O2 to the solution 
containing enzyme and substrate. Final reactions contained CmlI (20 μM), pAP or pABA 
(1 mM), 1.5% H2O2 (v/v) and 7% ethanol in MOPS buffer (50 mM, pH 7.4). The activity 
was quantified by HPLC as described below. To compare the stability and activity of the 
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assembled enzyme complexes with that of the free enzyme, a pre-treatment time course 
study was done with pre-incubation of P4VP-CmlI and free enzymes with 1.5% H2O2 (v/v) 
for 0 h, 1 h, 2 h, 5 h, then the activity test was followed. 
1.2.7 HPLC AND MS ANALYSIS 
Reactions with pAP were quenched by trifluoroacetic acid (final concentration 
2.5% v/v). Reactions with pABA were quenched using acetic acid (final concentration 1% 
v/v).  After quenching, samples were centrifuged at 15,000 g at 4 °C for 15 minutes and 
the supernatant was collected. Due to the sensitivity of aryl-nitroso compounds towards 
NADH,46 both P4VP-CmlI and free CmlI catalyzed reactions were analyzed by HPLC 
immediately after quenching and centrifugation. The products were identified and 
quantified using an Agilent 1100 series HPLC equipped with a ZORBAX SB-C18 column. 
HPLC parameters were as follows: 25°C; solvent A, 1% acetic acid in water; solvent B, 
methanol; gradient, 10% B for 2 min; then, from 10% B to 100% B over 18 min; flow rate, 
0.5 ml/min. Detection of the products resulting from pAP metabolism was by UV 
absorbance at 305 nm. Those from pABA reactions were monitored at 268 nm. 
Quantification was done based on the peak area of the corresponding compounds. LC-MS 
with electrospray ionization was carried out in Mass Spectrometry Center, USC to identify 
the pHABA. 
1.2.8 FMN REDUCTION RATE TEST 
MOPS 50 mM pH 7.4 buffer was degassed for 30 minutes before used for P4VP-
CmlI assembly, solutions of FMN (500 μM), NADH (50 mM) and P4VP- and free CmlI 
enzyme were degassed separately for 10 minutes and diluted with MOPS buffer before 
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each test. UV−Vis absorption studies were performed using an Agilent 8453 UV−Vis 
spectrometer (1 mm path length) with exposure of air. 
1.3 RESULT AND DISCUSSION 
1.3.1 P4VP-CMLI SYNTHESIS AND CHARACTERIZATION 
CmlI enzyme was purified by using nickel-nitriloacetic acid (Ni-NTA) affinity 
chromatography. The purity was identified by SDS-PAGE as shown in Figure 1.1. A 
robust one-step protocol for PPCS-NPs generation through co-assembly was described in 
detail in previous studies.36 In our work, P4VP polymer was dissolved in ethanol then 
added into CmlI enzyme solution drop wisely with vigorous stirring. After addition, the 
mixture was stirred for an additional 30 minutes for equilibration (Figure 1.2a). Because 
of the high loading capacity of the PPCS-NPs,36 the equilibrated P4VP-CmlI sample was 
used in the following morphology test and enzymatic assay without a further purification. 
Based on the FESEM results (Figure 1.2b), P4VP-CmlI core shell nanoparticles were 
successfully generated. Dynamic light scattering (DLS) analysis revealed the average 
diameter of P4VP-CmlI nanoparticles was around 200 nm and the polydispersity index 
(PDI) was 0.107, showing considerable homogeneous nanoparticles formed (Figure 1.2c). 
This was consistent with our previous research results.32,36 
 
Figure 1.1 SDS-PAGE of purified CmlI enzyme 
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Figure 1.2 (a) Schematic representation of the preparation of P4VP-CmlI in MOPS buffer 
at pH 7.4. (b) FESEM image of P4VP-CmlI nanoparticles. Inset shows an enlarged image 
of a single particle. (c) Size distribution of P4VP-CmlI nanoparticles based on DLS 
measurement. 
1.3.2 CATALYTIC ACTIVITY OF P4VP-CMLI 
Aside from reactions with the native NH2-CAM substrate, there is only limited data 
that defines the substrate scope for CmlI reactions.16 From transient kinetics measurements, 
it is known that the peroxo-CmlI adduct exhibits enhanced rates of decay in the presence 
of arylamine compounds with different para substituents including pAP, pABA and L-
pAPA (L-para-aminophenylalanine).19 However, the products for these reactions have not 
been identified. In this study, pAP and pABA were chosen as model substrates for 
characterizing P4VP-CmlI activity. Based on reported catalytic mechanism of CmlI, the 
nitro substituted compounds (pNP and pNBA) should be produced as the final six-electron 
oxidized products, while the analogous hydroxylamino- (pHAP and pHABA) and nitroso- 
compounds (pNOP and pNOBA) may be observed as intermediate products (Scheme 
1.2).17 It was reported that an arylamine N-oxygenase isolated from Pseudomonas syringae 
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pv. Phaseolicola (PsAAO), a closely-related ortholog of AurF and CmlI, could tolerate and 
even showed higher activity in the presence of methanol.21 We found that CmlI had similar 
characteristics, i.e. the presence of 7% ethanol increased the enzyme activity by 
approximately 50%. To get consistent results, the P4VP-CmlI NPs were tested in the 7% 
ethanol/MOPS co-solvent without further purification after the co-assembly. 
 
 
Scheme 1.2 Schematic representation of CmlI catalyzed reaction with pAP and pABA as 
substrate *The shaded products were observed with NADH/PMS method. 
The activity of P4VP-CmlI was reconstituted using a redox system composed of 
NADH and the mediator phenazine methosulfate (PMS). The activity was alternatively 
assessed with a peroxide-shunt method using 1.5% H2O2 (v/v). The pAP and pABA 
substrates tested here have opposing electrophilicities at the para substitution (Scheme 
1.2). Very interestingly, while both pAP and pABA could serve as substrates for CmlI, we 
observed that for pAP, the intermediate product pNOP, rather than the fully oxidized pNP, 
was accumulated for both the P4VP-CmlI and free CmlI catalyzed reactions using either 
method (Figure 1.3a, Figure 1.4). In contrast, when pABA was used as a substrate, the 
intermediate product pHABA was accumulated with the NADH/PMS method (Figure 
1.3d-f) and pNBA was accumulated with the peroxide-shunt method (Figure 1.5). For 
comparison, the ortholog AurF was reported to have activity with pABA, but no activity 
was observed with pAP.22 AurF also exhibits product distributions that depend on the 
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turnover methods utilized which was attributed to different reaction steps being rate- 
limiting.22 
The mechanisms why intermediate products can escape from the enzyme active 
center have not been well understood so far. In this study, smaller size of the two unnatural 
substrates by comparing their native counterpart could partially explain why they can easily 
release from the enzyme active center without fully oxidation. The proposed mechanism 
for CmlI catalysis invokes an amphiphilic nature of the peroxo-CmlI oxidant, which could 
perform electrophilic (for amine or hydroxylamino) or nucleophilic oxidations (for nitroso) 
of substrates respectively.17 Each of these would be expected to be highly sensitive to the 
nature of the para substituent. As a result, product distributions and activity would be 









Figure 1.3 Enzymatic activity analysis of P4VP-CmlI assemblies: 20 μM enzyme, 1 mM pAP or 1 mM pABA, 2 mM NADH and 25 
μM PMS in MOPS buffer (50 mM, pH 7.4). (a) HPLC analysis of the enzymatic oxidation products of pAP catalyzed with P4VP-CmlI. 
(b-c) Comparison of the activity of P4VP-CmlI and free CmlI using pAP based chromogenic assay, the signal at the first read was 
subtracted as background. (d-f) HPLC analysis of the oxidation products using pABA as the substrate with free CmlI (d) and P4VP-
CmlI as the catalyst (e) and the pure pABA (f). (g-h) Activity comparison based on the consumption of starting material pABA (g) and 
the production of the intermediate pHABA (h). Error bars represent the standard deviation of the mean of triplicate sample.
 
17 
With P4VP assembly, all these enzyme functions were maintained. It is noteworthy 
that the activity of enzyme assembly with NADH/PMS method showed around 1.6 to 2.3 
times increase compared to the activity carried out via the peroxide shunt method. In 
addition, the highly sensitive of P4VP-CmlI to NADH/PMS concentration, which will be 
discussed as below, makes the enzyme assemblies potentially used for synthetic 
applications. The enzyme activity results showed near-ideal enzyme activity behavior 
especially in the initial region. For longer reaction time, it showed a biphasic behavior. 
Although we still do not know the precise origins for such phenomenon, a similar 
observation has been also reported by another group.16 To the best of our knowledge, this 
study is the first report that, with different substrates, products at different oxygenation 
stages can be selectively enriched by CmlI. Continued investigation using a wider 
substrate-scope may reveal new opportunities for synthetic applications. 
1.2.3 ACTIVITY COMPARISON OF P4VP-CMLI AND FREE CMLI 
In order to compare the catalytic efficiency of P4VP-CmlI and free CmlI, the free 
enzyme was tested under the same conditions used in the preparation of P4VP-CmlI. For 
pAP with NADH/PMS method, reactions were monitored by absorbance spectroscopy ( 
= 405 nm) to monitor the production of pNOP (Figure 1.3b). The specific activity of 
P4VP-CmlI was as much as 5 times higher than that of the free enzyme (Figure 1.3c). For 
pABA, the activity of P4VP-CmlI was around ~ 1.6 times of that of free enzyme, as 
calculated by either the consumption of substrate (Figure 1.3g) or by pHABA production 







Figure 1.4 HPLC result of P4VP-CmlI assembly and free CmlI enzyme reaction with pAP with different assays (a-b) the reactions with 
2 mM NADH, 125 μM PMS (c-d) the reactions with 1.5% H2O2 (e) P4VP-CmlI catalyzed reaction with NADH/FMN (f) P4VP-CmlI 
catalyzed reaction with NADH/riboflavin. All the reactions were done in pH 7.4, 50 mM MOPS buffer at 30 minutes. (g) HPLC traces 







Figure 1.5 P4VP-CmlI and free CmlI activity test with H2O2 method using pABA as substrate. (a-b) Comparison based on the pABA 




The reaction of PMS and NADH has been reported to produce hydrogen peroxide,47 
which at high enough levels may contribute to enzyme activity. To test this possibility, 1 
μM catalase was included in the CmlI/pAP/NADH/PMS reaction. Only minor differences 
in activity were observed upon the addition of the H2O2 scavenger (Figure 1.6a). This 
suggests that CmlI catalysis from pyridine nucleotide likely proceeds by a reductive 
mechanism where the peroxo-adduct is formed from electron transfer and subsequent O2 
binding. To further explore why P4VP-CmlI exhibits enhanced turnover rate, the 
enzymatic activity assay with pAP was performed at different NADH/PMS concentrations. 
As expected, when both NADH and PMS were at higher concentrations (NADH 10 mM, 
PMS 125 μM), both P4VP-CmlI and free CmlI showed higher activity due to sufficient 
and fast electron delivery (Figure 1.6b). However, when the concentration of PMS was 
increased to 125 μM but the NADH kept at 2 mM, the difference between the activities of 
P4VP-CmlI and free CmlI became negligible due to the dramatically increased turnover of 
the free enzyme (Figure 1.6b). This implies that the electron transferring process mediated 
by PMS could be facilitated in the P4VP-CmlI reaction and this difference was masked by 
increasing PMS concentration. It is noteworthy that product formation time course by CmlI 
showed a lag-phase, possibly due to a side reaction between the nitroso intermediate and 
NADH/PMS.46 Interestingly, this effect can be rescued in the P4VP-CmlI catalyzed 
reaction (Figure 1.6b). This phenomenon could be attributed to potential interactions 




Figure 1.6 Enzymatic activity comparison of P4VP-CmlI and free CmlI with adding 
catalase (a), with different PMS/NADH concentration (b), with NADH/FMN or 
NADH/riboflavin system (c) and by peroxo-shunt method (d). For (a), 25 μM CmlI was 
used in CmlI/NADH/PMS reaction, 25 μM CmlI and 1 μM catalase were used in 
CmlI/NADH/PMS + catalase reaction. All the reactions were done with 2.5 mM NADH, 
125 μM PMS, 1 mM pAP, 7% ethanol in MOPS buffer (50 mM, pH 7.4). For (c), 1 mM 
NADH and 12.5 μM FMN or Riboflavin were used and the reaction was stopped at 60 
minutes. For (d), 1.5% H2O2 (v/v) was used. From (b) to (d), the reactions were done with 
20 μM enzyme, 1 mM pAP in MOPS buffer (50 mM, pH 7.4). Error bars represent the 
standard deviation of the mean of triplicate tests. 
Flavin mononucleotide (FMN) and riboflavin, common biological redox partners 
used in a plethora of redox processes,48–50 were utilized as alternative reducing systems. As 
shown in Figure 1.6c and consistent with the results from PMS, the activity of P4VP-CmlI 
was higher (~ 30%) than the free enzyme with pAP substrate. However, the overall 
efficiency was much lower than that of the NADH/PMS couple. Based on above data, we 
hypothesized that the origin of the enhanced activity for P4VP-CmlI may derive from an 
enhanced rate of electron delivery to form the diferrous cluster. To test this, the activity of 
P4VP-CmlI and free CmlI was compared to a peroxide-shunt method in which the 
reduction process was bypassed (Scheme 1). The result showed no significant activity 
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difference between the P4VP-CmlI and free CmlI (Figure 1.6d). This indicated that the 
enhanced activity of P4VP-CmlI using NADH was most likely from the enzyme reduction 
step. To further identify the effect of H2O2 on the stability and activity of peroxo CmlI 
intermediate in assembled and free conditions, the H2O2 pre-treatment study was 
performed. In this test, both P4VP-CmlI and free CmlI were pretreated with 1.5 % H2O2 
(v/v) and aged for different times prior to the addition of pAP. There was no significant 
difference between P4VP-CmlI and CmlI indicating uncompromised stability and activity 
of both samples (Figure 1.7). 
1.3.4 FMN REDUCTION TEST IN P4VP-CMLI AND FREE CMLI SOLUTIONS 
In order to further demonstrate that an enhancement in electron transfer conferred 
higher activity in P4VP-CmlI, the transfer of electrons from NADH to FMN was tested by 
optical spectroscopy. NADH, in its reduced form, absorbs at 340 nm and oxidized FMN at 
440 nm. The reduction of FMN by NADH can thus be monitored by the loss of absorbance 
at both wavelengths. The absorbance spectrum of P4VP-CmlI has background 
contributions due to scattering of the nanoparticles (Figure 1.8). As one could expect, 
oxidation of NADH occurs for both P4VP-CmlI and free CmlI due to the reaction of FMN 
and NADH. However, P4VP-CmlI shows a much faster rate of NADH oxidation (Figure 







Figure 1.7 P4VP-CmlI and free CmlI activity test with different time of H2O2 pretreatment using pAP as substrate. (a-f) HPLC result 
of corresponding reactions. (g) Activity comparison based on the pNOP production.
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Figure 1.9. Reduction test of FMN by NADH in P4VP-CmlI and free CmlI solution. (a) 
UV-Vis spectra of P4VP-CmlI solution (red) and free CmlI solution (black) at MOPS 
buffer. (b) Time resolved FMN (30 µM) in presence of NADH signal (200 µM) in P4VP-
CmlI and free CmlI solution. (c) Time courses for the reduction of FMN (50 µM) by NADH 
(5 mM) in P4VP-CmlI solution, free CmlI solution and MOPS buffer. 
1.4 CONCLUSIONS 
In this study, we have generated P4VP-CmlI core-shell nanoparticles via a facile 
self-assembly process and explored its activity with two substrates pAP and pABA using 
both oxidative and reductive turnover methods. Nitroso- and nitro- products could be 
selectively produced with different substrates using different co-substrates to initiate the 
reaction. We found that the P4VP assembly could significantly increase CmlI activity using 
NADH as an electron source and appropriate electron mediators. As redox partners are 
required for the efficient turnover of CmlI but have yet to be identified, reconstitution of 
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the enzyme activity in vitro is a major challenge. The P4VP polymer assembly system 
improves the reduction of the enzyme in the absence of protein-based redox partners, and 
as a result, showed significant enhanced activity. P4VP is an inexpensive polymer available 
at an industrial scale, and the polymer-enzyme co-assembly process is both robust and 
facile. The P4VP-CmlI nanoparticles reported here could thus be easily used for synthetic 
applications. 
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CHAPTER 2 
ENHANCED P450 OLETSA CATALYSIS PROMOTED BY COUPLING WITH 
GLUCOSE OXIDASE AND CO-ASSEMBLY 
31 
2.1 INTRODUCTION 
Driven by shortage of fossil fuel reserves and increasing environmental concerns, 
tremendous efforts have been undertaken to transform bio-based feedstock into 
chemicals1,2 and fuels3–5. Among them, the conversion of bioavailable carboxylic acids 
(e.g., fatty acids) into terminal alkenes attracts attention because of their applications as 
next-generation fuels and key chemicals for the production of lubricants, surfactants, 
detergents, plastics, etc.6–9 To achieve this goal, different methodologies have been 
developed such as esterification, amidation 10 and chemical reductions11,12. Despite of the 
success of these methods, the requirement of precious transition metal catalysts and the 
harsh reaction conditions often raise environmental concerns. Therefore, enzyme-catalyzed 
oxidative decarboxylation reactions that can directly produce terminal alkenes in mild 
conditions provide viable alternative approaches.13–15 
A promising enzymatic alternative, cytochrome P450 OleT from Jeotgalicoccus sp. 
8456, was first identified as an efficient olefin producer by Rude and coworkers.16 OleT 
catalyzes the oxidative decarboxylation of fatty acids to yield primarily terminal alkenes 
and CO2 or minor α- and β-hydroxylated fatty acids side-products.
16–18 Whereas the 
majority of P450s activate atmospheric O2 using pyridine dinucleotide as a reducing source 
and an auxiliary redox chain,19 OleT utilizes H2O2 as the only electron- and oxygen-source 
throughout the catalytic cycle (Figure 2.1a).20 Unlike NAD(P)H, H2O2 is inexpensive and 
easily scalable, and previous efforts have sought to rewire P450s for efficient peroxide 
utilization.21 However, the low turnover rate and low stability in the presence of excess 
H2O2 limit the practical use of OleT. Very recently, a functional ortholog from 
Staphylococcus aureus, OleTSA,
22,23 was characterized by the Makris group and others that 
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possesses improved features including enhanced solubility and high stability. These 
features enable this ortholog to be a promising candidate for production applications. 
 
Figure 2.1 a) Scheme of the cytochrome P450 OleT enzyme catalytic cycle. OleT is in a 
low-spin ferric resting state with its heme iron axially coordinated by cysteine thiolate and 
a H2O molecule, which shows a maximum Soret band at 418 nm.
24 Substrate binding 
displaces the axial water and converts the heme iron from low-spin to a high-spin state with 
a maximum Soret band at 394 nm.24 Subsequent H2O2 activation forms Compound I,
18 
which abstracts a hydrogen atom from the Cβ position (HAT step), resulting in formation 
of a substrate radical and the Fe4+-hydroxo species (compound II).25 Further substrate 
oxidation, and recruitment of a proton results in the elimination of CO2 (PCET step) and 
terminal alkene formation. b) Schematic representation of GOx/OleTSA cascade using 
glucose as a substrate to produce H2O2 in situ. 
One major issue of the H2O2-dependent biocatalysts towards their industrial 
applications is enzyme inactivation.26 High concentrations of peroxide will generally 
oxidize key amino acids (e.g. methionine, tryptophan) in the vicinity of enzyme active 
site27–29 or directly destroy the porphyrin cofactor, resulting in bleaching of the heme.30,31 
To alleviate this issue, different strategies have been explored such as enzyme 
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engineering,28,32–34 immobilization,35–37 or the development of in situ H2O2 production 
methods,38,39 Among them, controlling the concentration of peroxide during the catalytic 
reactions by employing in situ generation techniques provides a facile way to reduce the 
peroxide-related enzyme inactivation.26,40,41 To date, photochemical and biological 
approaches that generate H2O2 in a controlled manner have been reported to leverage OleT 
enzyme catalysis. Zachos and colleagues described an in situ H2O2-generation system that 
uses light to excite flavin cofactors with ethylenediaminetetraacetic acid (EDTA) as an 
electron donor, which converts dioxygen to H2O2 to active the OleTJE enzyme for terminal 
alkene production.42,43 Matthews et al. reported an enzyme genetic fusion system in which 
OleTJE was linked to alditol oxidase (AldO). With this system, polyol substrates were fed 
as AldO substrates to generate H2O2.
44 
In this work, we report the use of glucose oxidase (GOx) and sugars as substrates 
to efficiently drive OleTSA catalysis in an adjustable manner (Figure 2.1b). GOx is a 
flavoenzyme that metabolizes D-glucose by using molecular oxygen as an electron acceptor 
with simultaneous production of H2O2.
45 GOx is widely used in food, textile, and glucose-
sensing industries because of its high stability and catalytic efficiency.46 Other substrates 
of GOx include D-mannose, D-galactose and D-xylose,
47 which are all abundant and 
renewable feedstocks. Moreover, GOx has significantly varied kinetics with different 
substrates,47,48 which enables one to regulate the H2O2-generating process. The data 
presented in this manuscript demonstrates improved catalytic efficiency of OleT enzyme 
when coupled with the GOx enzyme (the GOx method) compared to a single injection of 
H2O2 (the H2O2 method). We rationalize that the GOx-based in situ H2O2-generation 
method poises H2O2 concentrations at a level compatible with OleT catalysis while 
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minimizing the heme destruction during the catalysis. Finally, we use a poly(4-
vinylpyridine) (P4VP) polymer to co-assemble GOx and OleTSA enzymes to generate 
nanoparticles (NPs) in order to further optimize enzyme cascade catalytic efficiency. The 
combination of the GOx-based method and the dual enzyme co-assembly with polymers 
provides a novel way to leverage OleT enzyme catalysis, which can be potentially used for 
synthetic applications. 
2.2 EXPERIMENTAL SECTION 
2.2.1 MATERIALS 
GOx from Aspergillus niger and H2O2 were purchased from Sigma. Eicosanoic acid 
(C20:0), stearic acid (C18:0), palmitic acid (C16:0), myristic acid (C14:0), lauric acid 
(C12:0), and capric acid (C10:0) were purchased from BDH Chemicals. The alkene 
standard 1-hexadecene was purchased from TCI chemicals. D-Glucose, D-mannose, D-
galactose were purchased from Fisher. Hydrocinnamic acid, 3-(4-bromophenyl) propionic 
acid, indole-3-butyric acid, 3-(4-methoxyyphennyl) propionic acid and P4VP (Mw 60000) 
were purchased from Sigma-Aldrich. N,O-Bis(trimethylsilyl)trifluoroacetamide 
(BSTFA)/trimethylchlorosilane (TMCS) (99:1) were purchased from Supelco (Bellefonte, 
PA, USA). Unless otherwise noted, all chemicals and solvents used were of analytical 
grade and were used as received from commercial sources. Unless otherwise noted, 200 
mM K2HPO4, 100 mM NaCl, pH 7.4 was used as buffer. 
2.2.2. HETEROLOGOUS EXPRESSION AND PURIFICATION OF OLETSA 
The original OleTSA gene was synthesized and codon optimized for E. coli 
expression by Bio Basic Inc. (Markham, Ontario). The gene was subcloned onto a 
kanamycin-resistant T5 plasmid pJ401containing a C-terminal HisTag. The construct was 
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transformed into BL21(DE3) containing the pTF2 plasmid encoding for GroEL/GroES/Tig 
onto a kanamycin (50 μg/mL)/chloramphenicol (30 μg/mL) LB plate. Modified Terrific 
Broth (TB) (24 g/L yeast extract, 12 g/L tryptone, 4 g/L peptone) supplemented with 50 
μg/mL kanamycin and 20 μg/mL chloramphenicol was used to grow a cell culture from a 
single colony overnight at 37 °C. For protein expression, 10 mL of this starter culture was 
used to inoculate 500 mL of TB containing 50 μg/mL kanamycin, 30 μg/mL 
chloramphenicol, 125 mg/L thiamine, and trace metals.22 The cultures were grown to an 
OD600 nm of 1.0, at which point protein expression was induced with 100 μM IPTG, 10 
ng/mL tetracycline and 10 mg/L of 5-aminolevulinic acid. The culture was incubated at 18 
°C for an additional 16-18 h and harvested by centrifugation for purification or for storage 
at -80 °C until further use. The protein was purified using nickel-nitriloacetic acid (Ni-
NTA) affinity chromatography followed by Butyl-S-Sepharose column purification as 
described previously.22 Fractions with an Rz value (Abs418 nm/Abs280 nm) above 1.2 were 
pooled and dialyzed against 200 mM KPi pH 8. Proteins were stored at -80 °C until further 
use. Enzyme purity was assessed by SDS-PAGE. 
2.2.3. OLETSA ENZYME ACTIVITY ASSAYS 
Eicosanoic acid and stearic acid stock (10 mM) were dissolved in 70% ethanol/30% 
Triton X-100 (unless otherwise noted) as stocks. Other fatty acids including palmitic acid, 
myristic acid and lauric acid were dissolved in DMSO to make 10 mM stocks. 
Hydrocinnamic acid was dissolved in DMSO to make a 400 mM stock. To set up enzymatic 
reactions, 5 μM OleTSA, 500 μM or 1 mM fatty acids or 1 mM hydrocinnamic acid (unless 
otherwise noted) from above stocks were used for multiple-turnover reactions in a 150 μL 
volume. H2O2 was added at a concentration of 2 mM to initiate the reactions in H2O2 
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method, while 10 nM to 5 μM GOx was added to initiate the reactions in GOx method. D-
glucose, D-mannose, or D-galactose (6.6 mM) were used in the GOx method unless 
otherwise noted. The steady-state reactions were quenched with 0.4 mM HCl or 1% acetic 
acid for GC/GC-MS or LC/LC-MS analysis, respectively. 
2.2.4. HEME DECAY MONITORING 
Heme decay was monitored with UV-Visible spectroscopy on an HP 8453 
spectrophotometer. A quartz cuvette with 1 cm path length was used. For the heme decay 
monitoring during GOx- or H2O2-driven reactions, 5 μM OleTSA, 0.5 mM eicosanoic acid 
in the presence of 2 mM H2O2 or 10 nM GOx and 6.6 mM glucose were used. OleTSA 
spectra were recorded over time for 1 h at room temperature. Active enzyme concentration 
was determined from the total thiolate-ligated heme in the sample, based on the extinction 
coefficients of the Soret peaks: at 418 nm, 112.8 mM-1cm-1 for low-spin fraction, 56.6 mM-
1cm-1 for high-spin fraction; 86.8 mM-1cm-1 at 406 nm; at 394 nm, 50 mM-1cm-1 for low-
spin fraction, 106.5 mM-1cm-1 for high-spin fraction.22 
2.2.5. GAS CHROMATOGRAPHY (GC) ANALYSIS 
For gas chromatographic quantification of fatty acid metabolism by OleTSA, 
internal standards including 1-hexadecene and a Cn-2 fatty acid (relative to substrate of 
chain-length Cn) were added after the reactions were quenched with 300 mM HCl. The 
reactions were extracted with 300 μL chloroform. The organic phases of each reaction were 
tested on GC directly or derivatized before GC analysis. For derivatization, samples were 
concentrated under a stream of N2 gas to less than 50 μL, then derivatized with 250 molar 
equivalents of BSTFA: TMCS (99:1). Samples were incubated at 60 °C for 20 minutes for 
trimethylsilylation. Following the derivatization, samples were analyzed by GC. The 
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following oven conditions were used to detect products of C20 through C16 fatty acids: 
170 °C for 3 min, 10 °C/min to 220 °C, 5 °C/min to 320 °C, and 320 °C for 3 min. The 
following oven conditions were used to detect products of C14 and C12 fatty acids 
metabolism: 100 °C for 3 min, 5 °C/min to 250 °C and 250 °C for 3 min. The response 
factors between fatty acids, hydroxyl fatty acids and alkenes were determined by analyzing 
known authentic fatty acids (C18-C10) and 1-hexadecene standards. 
2.2.6. HPLC AND MS ANALYSIS 
Reactions (total volume = 150 μL) with hydrocinnamic acid were quenched by 
acetic acid (final concentration 1% v/v). After quenching, 1,2,3,4-tetramethyl benzene was 
added as internal control and the mixture was extracted with ethyl acetate (300 μL). For 
each sample, 20 μL of organic layer was were injected in an Agilent 1100 HPLC equipped 
with a ZORBAX SB-C18 column. HPLC parameters were as follows: 25 °C; solvent A, 
1% acetic acid in water; solvent B, methanol; gradient, 10% B for 2 min; then, from 10% 
B to 100% B over 32 min; then, from 100% B to 10% B over 10 min, flow rate, 0.5 mL/min. 
Detection of the products was by UV absorbance at 250 nm. Quantification of product was 
calculated from a calibration curve of styrene with the same extraction method. The 
identity of the styrene product was confirmed by LC-MS at the Mass Spectrometry Center, 
University of South Carolina. 
2.2.7. SYNTHESIS OF P4VP-GOX-OLETSA ASSEMBLIES AND 
CHARACTERIZATION 
A solution of P4VP in ethanol (2.5 mg·mL-1, 0.1 mL) was slowly added to a 
solution containing 1 µM OleTSA and 1 µM GOx in buffer A (0.9 mL) with stirring. After 
addition, the mixture was stirred for an additional 10 min for equilibration. Because of the 
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high loading capacity,49 the co-assemblies was not purified before characterization and 
activity test. The size distribution of P4VP-GOx-OleT assemblies were measured with 
dynamic light scattering (DLS, Zetasizer Nano ZS, Malvern Instruments). For TEM 
analysis, P4VP-GOx-OleT samples prepared above were diluted 10 times with water, and 
20 μL of diluted samples were dropped onto 250-mesh carbon-coated copper grids and 
dried. The grids were observed with a Hitachi H-8000 electron microscope at the Electron 
Microscopy Center, University of South Carolina. 
2.2.8. ACTIVITY COMPARISON OF P4VP-GOX-OLETSA ASSEMBLIES AND FREE 
GOX/OLET ENZYME CASCADE 
The activities of both P4VP-GOx-OleTSA and free enzyme cascade were assessed 
in a reaction volume of 250 μL containing GOx and OleTSA (1 μM/each), hydrocinnamic 
acid (2 mM) or myristic acid (1 mM). Reactions were initiated by the addition of mannose 
(6.6 mM) to the reaction mixture and incubated at room temperature (23 – 25°C). In the 
control reactions, GOx and mannose were omitted from the reaction sample and instead, 2 
mM H2O2 was used to initiate the reactions. A stock solution of 400 mM hydrocinnamic 
acid was prepared in DMSO. The final organic solvent concentration in the reaction is 
4.1% ethanol and 1% DMSO for each sample. The reaction was quenched by the addition 
of 1% acetic acid, and an internal standard of 1,2,3,4-tetramethyl benzene was added. The 
products were exacted with 300 μL ethyl acetate and analyzed by LC or GC as described 
above. 
2.2.9. CATALASE COMPETITION ASSAY 
Catalase, as a scavenger for H2O2, was added to the enzymatic reactions catalyzed 
by assembled enzyme cascade (P4VP-GOx-OleTSA) and free GOx/OleTSA to measure the 
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differences. A serial concentration of catalase from 15.6 nM to 250 nM was added into the 
reaction mixtures containing GOx and OleTSA (1 μM/each), hydrocinnamic acid (2 mM), 
and mannose (6.6 mM). As above, the reactions were initiated by the addition of mannose 
and quenched by the addition of 1% acetic acid, and 1,2,3,4-tetramethyl benzene was added 
as internal standard. The reactions were exacted by 300 μL ethyl acetate and analyzed by 
LC. 
2.3 RESULTS AND DISCUSSION 
2.3.1 H2O2 CONCENTRATION DEPENDENCE OF OLETSA ACTIVITY AND HEME 
BLEACHING 
OleTSA enzyme was purified using Ni column affinity chromatography followed 
by hydrophobic interaction chromatography (Butyl-Sepharose) (Figure 2.2). As shown in 
Figure 2.3a, a certain level of H2O2 is necessary to drive OleTSA enzymatic catalysis to 
form oxidizing species known as Compound I. However, with excess H2O2, the enzyme  
displays low substrate conversion,41,50 suggesting peroxide-mediated enzyme inactivation. 
To characterize the H2O2 concentration dependence of OleTSA enzymatic activity, varying 
concentrations of H2O2 were added in the enzyme reaction with eicosanoic acid as the 
substrate. Nonadecene production (which is the sole product of eicosanoic acid reaction)22 
was used to calculate the product conversion rate. As shown in Figure 2.3a, with increasing 
H2O2 concentration from 0.05 mM to 2 mM, increased conversions from 4% to 12% were 
obtained. On the other hand, increasing the H2O2 concentration further from 2 mM to 40 
mM led to a decreased conversion. A similar trend was also observed for OleTSA-catalyzed 
styrene production using hydrocinnamic acid as substrate (Figure 2.4). These results 




Figure 2.2 SDS-PAGE gel of the purified OleTSA 
 
 
Figure 2.3 The H2O2 concentration dependence of OleTSA enzyme activity (a) and the 
Soret band intensity (b-c). (a) Comparison of the reaction rate of the conversion of 
eicosanoic acid to nonadecene by OleTSA with various H2O2 concentrations. The reaction 
conditions are as follows: OleTSA 5 μM, eicosanoic acid 1 mM, H2O2 0.05 mM - 40 mM, 
room temperature for 30 min. Error bars indicate the standard deviation of two independent 
experiments (n = 2). (b) The UV-Vis spectra of 5 μM OleTSA was recorded immediately 
after adding varying concentrations of H2O2. The arrow indicates the increase of H2O2 
concentration. (c) Absorbance monitoring of 5 μM OleTSA treated with 2 mM H2O2 from 
20 s to 60 min. The arrow indicates the increase of incubation time. (d) The UV-Vis spectra 
of 5 μM OleTSA was recorded after treating with varying concentrations of H2O2 for 15 
min. (f) The UV-Vis spectra of 5 μM OleTSA was recorded after treating with varying 
concentrations of H2O2 for 30 min. Protein aggregation was observed with high 
concentration of H2O2 treatment and longer time incubation, which causes high scattering. 
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Figure 2.4 H2O2 concentration dependence test for OleTSA catalysis with hydrocinnamic 
acid. Reaction condition: OleTSA 5 μM, hydrocinnamic acid 4 mM, reaction at room 
temperature for 60 minutes. 
The destruction of the heme group of P450s and unspecific peroxygenases by H2O2 
or other reactive intermediates such as superoxide anion (O2-) and hydroxyl radical (•OH)  
has been widely reported.29,51,31 Because the intact heme has prominent optical features, 
heme degradation can be easily monitored by the loss of these features.31 In the low-spin 
ferric resting state, the most intense optical peak of P450s is the Soret band, which is 
centered at 418 nm for substrate-free low-spin OleTSA.
22,24 As shown in Figure 2.3b, upon 
the injection of increasing concentrations of H2O2 from 0.05 mM to 40 mM, the Soret band 
absorption of OleTSA decreases, implying heme destruction with H2O2 treatment. More 
serious heme bleaching and protein precipitation occurs upon longer incubation with high 
concentration of H2O2 (Figure 2.3d and 2.3e). Even with 2 mM H2O2, a condition in which 
the enzyme shows maximized conversion rate (Figure 2.2a), significant heme bleaching 
can be observed over time in Figure 2.3c. These results suggest that heme destruction is a 
key factor that limits OleTSA catalysis, and thus maintaining a compatible H2O2 
concentration during the reaction could potentially improve OleTSA catalytic efficiency. 
Slow H2O2 perfusion or fed-batch method have been used to circumvent the heme issue.
41,23 
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In this contribution, we propose to use a GOx enzyme-based in situ H2O2-generating 
method to leverage OleTSA catalysis. 
2.3.2 EFFECT OF DIFFERENT GOX SUBSTRATES ON THE ENZYME CASCADE 
CATALYSIS 
It has been reported that GOx not only efficiently oxidizes D-glucose but also 
consumes different sugars including D-mannose, D-galactose and D-xylose among others 
with slower reaction rates,47,48,52 which provides a useful method to tune the rate of H2O2-
generation to better optimize OleT catalysis. To maximize the potential of a multi-enzyme 
system, kinetic matching of each enzymatic reaction is important.53–55 In order to optimize 
the stoichiometry of GOx and OleTSA in the tandem catalysis reaction, different 
concentrations of GOx were tested with fixed concentrations of OleTSA and varying sugar 
substrates. As shown in Figure 2.5a, with glucose as a substrate, 10 nM GOx (0.002 molar 
equivalents to OleTSA) leads to maximized substrate conversion. Upon further increasing 
the GOx concentration, the product yield decreased, which could be caused by enzyme 
inactivation due to excess H2O2 produced from the GOx/glucose reaction. When mannose 
or galactose was used, at least one molar equivalent of GOx to OleTSA was needed to 
maximize the conversion rate. A similar phenomenon was observed in the assay where 
hydrocinnamic acid was metabolized by OleTSA to produce styrene (Figure 2.6). However, 
it is noteworthy that upon increasing the mannose concentration up to 13 mM, styrene 
production continued to rise (a ~30-50% increase, depending on the different GOx 
concentration) (Figure 2.6 inset). 
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Figure 2.5 OleTSA catalysis can be driven by different sugars with optimized GOx enzyme 
concentration. (a) Comparison of the conversion of eicosanoic acid with the OleTSA/GOx 
catalysis in a 60 min reaction time. (b) A time course comparison with GOx_Glucose and 
GOx_Mannose as H2O2 source vs. direct addition of H2O2 (2 mM). An exponential model 
was used to fit the data in (b). Reaction conditions were as follows: OleTSA 5 μM, sugars 
6.6 mM, eicosanoic acid 1 mM, GOx (concentrations as indicated) at room temperature. 
Error bars indicate the standard deviation of duplicate experiments (n = 2). 
A typical time course of product formation with the optimized GOx/OleT ratio is 
shown in Figure 2.3b. Decarboxylation continues to proceed until the end of the test (2 
hours) in the GOx method, demonstrating clear advantages of enzyme utility by comparing 
with that in the H2O2 method. As a control, a glucose titration test with GOx method shows 
increasing OleTSA activity with increasing glucose concentration, while with H2O2 method, 
glucose had no such effect, indicating that the enhancement of activity by glucose only 
occurs when paired with GOx (Figure 2.7). It is apparent that controlling the in situ H2O2-
generation rate to maintain an appropriate H2O2 level during OleTSA catalysis is important 
to maximize its enzymatic conversion. In summary, the GOx method shows significantly 
improved OleTSA catalytic efficiency than the H2O2 method, while GOx enzyme pairing 
with different sugars makes the method flexible to leverage OleT enzyme catalysis. Based 
on this, we demonstrated the kinetic matching of the tandem catalysis may be an important 
parameter to optimize the enzyme cascade efficiency. 
44 
2.3.3. GOX/OLETSA ENZYME CASCADE CATALYSIS TEST WITH DIFFERENT 
FATTY ACIDS 
Abundant and bioavailable fatty acids provide a renewable source for the 
sustainable production of terminal alkenes. To improve conversion yield has been a major 
pursuit for the OleT enzyme’s application.14,44 Here, we tested the GOx/OleTSA enzyme 
cascade activity with a selection of fatty acids including eicosanoic acid, stearic acid, 
palmitic acid, myristic acid and lauric acid using glucose as a GOx substrate at the 
optimized condition (molar ratio of GOx:OleTSA = 1:500) as described above. By 
comparison to the one-time H2O2 injection method, GOx method exhibits 25% to 300% 
higher conversion of substrate to product depending on the fatty acid substrate used (Table 
2.1). The chemo-specificity of enzymatic catalysis was similar in both two methods of 
peroxide addition (Table 2.2). In addition, with long-term reactions, the GOx method 
showed further increased substrates conversion, while there was no improvement with time 
in the H2O2 method (Table 2.3), which supports our hypothesis the function of OleTSA is 
irreversibly hampered by a high-volume addition of H2O2. By comparing different methods 
used for the OleT enzymatic reaction reported in literature so far, our method provides a 
simple and efficient way to improve the enzyme catalysis (Table 2.4). 
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Figure 2.6 OleTSA catalysis can be driven by different sugars in presence of different 
concentration of GOx enzyme. Reaction condition: OleTSA 5 μM, sugars 6.6 mM, 
hydrocinnamic acid 4 mM, room temperature for 60 minutes. 2 mM H2O2 was used in the 
H2O2 method as control. Inset: GOx titration test with 13 mM mannose and 4 mM 
hydrocinnamic acid at room temperature for 60 minutes. 
  
Figure 2.7 Glucose titration with GOx method. Reaction condition: OleTSA 5 μM, 
eicosanoic acid 1mM at room temperature, 30 minutes. Same operation was done with 
H2O2 method to exclude the glucose effect on the enzyme activity.  
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Table 2.1 OleTSA metabolic profile with different FAs with either the GOx or H2O2 
method.  
Substrate Method Alkene (%) Alcohol (%) Conv. (%) 
eicosanoic acid*  
GOx >99 NA 50 ± 5 
H2O2 >99 NA 12 ± 2 
stearic acid*  
GOx >99 <1 71 ± 3 
H2O2 >99 <1 57 ± 1 
palmitic acid  
GOx 62 38 93 ± 7 
H2O2 49 51 23 ± 4 
myristic acid  
GOx 63 37 99 ± 3 
H2O2 60 40 75 ± 5 
lauric acid  
GOx 59 41 92 ± 7 
H2O2 50 50 71 ± 5 
Reaction conditions are as follows: 5 μM OleTSA, 0.5 mM fatty acid substrate, and either 
0.01 μM GOx with 6.6 mM glucose or 2 mM H2O2. The reaction was in a total volume of 
300 μL and carried out at room temperature for 60 min. *The C20 and C18 fatty acid was 
dissolved in 70% ethanol/30% triton-100 as stock. All other fatty acids were dissolved in  
DMSO as stock.  
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stearic acid  
GOx <1% 
H2O2 <1% 
palmitic acid  
GOx 8% α, 63% β, 29% γ 
H2O2 3% α, 97% β, NA γ 
myristic acid  
GOx 26% α, 75% β, γ NA 
H2O2 19% α, 81% β, γ NA 
lauric acid  
GOx 11% α, 73% β, 16% γ 
H2O2 4% α, 96% β, γ NA 
a Reaction condition: OleTSA 5 μM, FAs 500 μM, 10 nM GOx, 6.6 mM glucose for 1 
hour. Alcohol products distribution was calculated based on the according peak areas.  
b Reaction condition: OleTSA 5 μM, FAs 500 μM. 5 mM H2O2 was perfused with pump 
within 2 hours. The Cβ regiospecificity is defined as the fractional percentage of alkenes 
and Cβ-alcohols over total products formed by the enzyme. 
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Table 2.3 OleTSA metabolism profile with different FAs with GOx and H2O2 method for 
overnight reactions 




GOx >99% NA >99% 
H2O2 >99% NA 13 ± 4 
stearic acid 
GOx >99% <1% 35 ± 2 




GOx 63 37  94 ± 3 
H2O2 41 59 35 ± 1 
myristic acid 
GOx 79 21 >99% 
H2O2 60 40 81 ± 3 
lauric acid 
GOx 74 26 >99% 
H2O2 47 53 75 ± 13 
Condition: OleTSA 5 μM, substrate 0.5 mM, GOx 0.01 μM, glucose 6.6 mM or H2O2 2 
mM, 300 μL reaction at room temperature for overnight. * The C20 fatty acid was 
dissolved in 70% ethanol/30% triton-100 as stock. All other fatty acids were dissolved in 
DMSO as stock.  
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In entry 3 and 4, a dehydrogenase-based NADPH regeneration system was coupled. In 
entry 8, the molar ratio of OleT to GOx was kept as 500:1. 
2.3.4. HEME DESTRUCTION IS PREVENTED USING THE GOX METHOD OF H2O2 
ADDITION 
The improved OleTSA enzyme catalytic activity with GOx method was attributed 
to a gradual and robust production of H2O2 that prevents heme degradation during the 
tandem catalysis. To confirm this hypothesis, OleTSA spectra were monitored during the 
enzymatic reactions with either one-time H2O2 addition or the gradual introduction using 
GOx (Figure 2.8a and 2.8b). The Soret peak was used as a handle for monitoring heme 
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integrity. As expected, OleTSA enzyme shifts from the high-spin (substrate-bound) state to 
the low-spin (substrate-free/product-bound) state spontaneously upon treatment with 2 mM 
H2O2, and stays predominantly in this state for the remainder of the time course test. We 
have previously determined in OleTJE that product release is significantly slower than the 
chemical steps (e.g. H2O2 activation, C-H abstraction) that lead to alkene generation,
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consistent with the spectra obtained here. Within minutes, the heme chromophore bleaches 
during the H2O2 treatment. On the other hand, with the GOx method, the low-spin Soret 
maximum at 418 nm appears after 5 min of reaction, indicating most of the proteins are 
substrate-free/product-bound like that of the H2O2 method, which suggests there is a burst 
of H2O2 during this period. Then, the enzyme returns to predominantly high-spin state for 
the remainder of the assay. This indicates that the majority of the OleTSA is in the substrate-
bound state and that H2O2 production by GOx is now rate-limiting. And the sluggishness 
of peroxide generation protects the heme from H2O2-mediated degradation to afford the 
higher overall turnover numbers shown above. As quantitative confirmation, the Soret peak 
intensity (as the sum of high-spin and low-spin) was used to determine the fraction of active 
enzyme throughout the time course study. As shown in Figure 2.8c, more than half of 
enzyme was inactivated within 1 h in the H2O2 method, whereas with the GOx method, the 
amount of active OleTSA enzyme remained unchanged after 1 hour, which is consistent 
with the observation that OleTSA is continually active during this time period (Figure 2.5b).  
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Figure 2.8 Soret band monitoring during OleTSA catalytic reactions with H2O2 method (a) 
and GOx method (b). In all reactions, 5 μM OleTSA, 0.5 mM eicosanoic acid, 2 mM H2O2 
or 10 nM GOx, 6.6 mM glucose were used. (c) Active OleTSA enzyme fraction comparison 
during the catalytic reactions with GOx and H2O2 methods. 
2.3.5. POLYMER-GOX-OLETSA ASSEMBLY TO IMPROVE ENZYME CASCADE 
CATALYTIC EFFICIENCY 
Inspired by natural multienzyme complexes that exhibit extraordinary 
efficiency,57,58 a variety of enzyme cascades have recently been developed via co-
localization of enzymes on nanostructured scaffolds59–67 to enable cooperative catalytic 
mechanisms such as facilitating intermediate transportation,59,60 kinetic modification via 
enzyme or intermediate substrate scaffold interactions,59,63 stoichiometry optimization,61 
and encapsulation,65,66 etc. We therefore attempted to co-assemble GOx/OleTSA enzyme 
pairs on a polymeric support to further promote enzymatic catalysis. In our previous 
studies, we used P4VP and other polymers to co-assemble different proteins to generate 
core-shell nanoparticles (NPs) 48,64,65,66 and demonstrated a high protein loading capacity 
and a close proximity of proteins on the surface of the NPs.49,71 Both the fine balance 
between hydrophobicity and hydrophilicity as well as the hydrogen bonding between 
proteins and polymers provide a benign environment for proteins to maintain their 
functions. Herein, we use this strategy to co-assemble GOx and OleTSA enzymes (Figure 
2.9a) in order to improve the enzyme cascade catalytic efficiency. With the assumption 
that the two enzymes have equal chance to attach to the NPs surface, equal molar 
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concentration of GOx and OleTSA (1 μM/each enzyme) was used for the co-assembly. TEM 
and DLS analysis shows successfully assembled polymer-dual-enzymes NPS with an 
average size of ~385 nm (Figure 2.9c). For tandem catalytic reactions, mannose was fed, 
hydrocinnamic acid or myristic acid was used as an OleTSA substrate to compare the 
activity of the assemblies to enzymes in solution. As shown in Figure 2.9d and Figure 
2.10, P4VP-GOx-OleTSA assemblies exhibit around 35-40% higher activity than the free 
GOx/OleTSA in a 60-min reaction at room temperature with different OleTSA substrates. 
As a control, the mixture of P4VP-GOx and P4VP-OleTSA assemblies showed 
comparable activity with the free enzymes (Figure 2.9d). Moreover, with dilutions, the  
co-assembled samples showed further enhanced activity compared to the free enzymes (~ 
60% enhanced activity was observed with 5 × times dilution of each sample, Figure 2.11). 
These results suggest that improved activity of the co-assemblies is related to the closed 
space of enzymes because of the co-localization on the NPs. In addition, if H2O2 instead of 
mannose was used to drive the catalysis, P4VP-GOx-OleTSA did not exhibit any enhanced 
activity comparing to the free enzymes (Figure 2.12).  
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Figure 2.9 (a) Schematic illustration of the preparation of P4VP-GOx-OleTSA in 
buffer/ethanol co-solvent. (b) Model of H2O2 diffusion on the surface of P4VP-GOx-
OleTSA assemblies. The pink color represents hydration layer on the NPs surface. (c) TEM 
image of P4VP-GOx-OleTSA assemblies; inset: DLS analysis shows the size distribution 
of P4VP-GOx-OleTSA assemblies. (d) P4VP-GOx-OleTSA assemblies show enhanced 
activity than free enzyme cascade for styrene production with 6.6 mM mannose as sugar 
source, and 2 mM hydrocinnamic acid as the substrate. An exponential model was used to 
fit the data. (e) Inhibition effect of catalase on the reactions catalyzed by P4VP-GOx-
OleTSA and free GOx/OleTSA mixtures. The reaction condition was the same as in (d) and 
were quenched after 60 minutes’ incubation. Error bars indicate the standard deviation of 
duplicate experiments (n = 2). 
 
Figure 2.10 (a) P4VP-GOx-OleTSA assemblies show enhanced activity than free enzyme 
cascade for C13 alkene production. Myristic acid (1 mM) was used as the substrate and 
mannose (6.6 mM) was fed in the reaction. (b) GC spectrum of the activity comparison. 




Figure 2.11 Activity enhancement was enlarged with dilution of P4VP-GOx-OleTSA NPs 
and free GOx/OleTSA solution. (a) Styrene production test of the samples with different 
dilutions. Condition: GOx and OleTSA (1 μM/each), hydrocinnamic acid (2 mM), Mannose 
(6.6 mM) in 500 μL reactions were used for all samples. 0.2 mg/mL P4VP was used for 
the co-assembly. Inset: the pictures of P4VP-GOx-OleTSA samples with different dilutions. 
The clean tubes contain free enzymes reactions. The cloudy tubes contain P4VP-GOx-
OleTSA assemblies catalyzed reactions. The pictures were taken after the 2 hours’ reaction 
at RT. (b) Activity comparison of P4VP-GOx-OleTSA samples and free GOx/OleTSA 
samples with different dilutions. 
 
Figure 2.12 Activity comparison of P4VP-GOx-OleTSA assemblies and free enzyme 
cascade with H2O2 method. hydrocinnamic acid (4 mM) was used as substrate. H2O2 (2 
mM) was used with 30 minutes’ reaction. Error bars indicate the standard deviation of 
duplicate experiments (n =2). 
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To further confirm whether the activity enhancement is due to proximity effects, 
catalase, a scavenger of H2O2, was added to challenge the tandem catalysis. As shown in 
Figure 2.9e, the reactions catalyzed by P4VP-GOx-OleTSA was much less inhibited by 
catalase than that of free enzymes. For example, when 250 nM of catalase was included in 
the reactions, P4VP-GOx-OleTSA still showed ~30% activity, while only 15% activity was 
observed for free enzymes. This result suggests that on the surface of NP assemblies, some 
H2O2 produced by GOx is transferred to OleTSA directly and is not freely defused into the 
bulk solution due to the closed proximity of the enzymes. We rationalize that in this system, 
large amount of enzyme pairs assembled on the nanoparticles surface may provide multiple 
local targets for H2O2.
72,73 Moreover, the very closed distance of the enzymes may create 
a hydration layer74 on the surface of NPs, which facilitates H2O2 transportation among 
enzymes,59 making a high local concentration of H2O2 around the OleTSA enzymes. All 
these factors may contribute to the enhanced GOx/OleTSA enzymatic activity when adhered 
to NP surfaces. However, the modest activity improvement and the slight sensitivity to 
catalase suggest the assembly is unable to directly tunnel H2O2 (Figure 2.9b), which could 
be the reason why only a relatively weak enhancement compared to other encapsulation 
systems.65,75 Nevertheless, the combination of the GOx-driven OleTSA catalysis and the co-
localization of the enzyme pairs on polymeric NPs through co-assembly demonstrated an 
efficient way to improve the cascade enzymatic catalysis. 
2.4. CONCLUSION 
In this study, we report the use of a GOx enzyme-based in situ H2O2-generating 
method to drive OleTSA catalysis to produce terminal alkenes with significantly improved 
substrate conversion than the one-time addition of peroxide. By monitoring the heme using 
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UV-visible spectroscopy during the reaction, we confirmed that the enhancement was due 
to the minimized heme degradation in the GOx method. By adjusting the GOx/OleTSA 
molar ratio and using different sugars, our system provides a flexible method to tune the 
H2O2-generating process and thus to leverage the catalysis of OleTSA. In particular, when 
glucose is used, only 0.002 molar equivalents of GOx are required to efficiently drive 
OleTSA catalysis. This not only demonstrates a simple approach to improve the isolated 
OleT enzyme catalysis in vitro but also provides new perspective for alkene production in 
vivo.76–78 With this enzyme cascade model, a facile P4VP polymer-dual enzyme co-
assembly was developed to further optimize the enzyme cascade catalytic efficiency 
through enzyme co-localization. Overall, the GOx-based in situ H2O2-generation method 
with OleTSA represents a simple and efficient strategy to transform bioavailable feed stocks 
such as fatty acids to industrially important chemicals. 
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3.1. INTRODUCTION 
Polymeric nanoparticles (PNPs), because of their small size, high surface-area-to-
volume ratio, and easy tunable physical and chemical properties, have gained great 
attentions in materials science.1,2 Through chemical modification of polymer chains3 or 
conjugation with distinct functional molecules ( e.g. inorganic or organic molecules, lipids, 
peptides, and proteins),4–8 PNPs could be tailored with customized properties, and were 
found numerous applications in the fields of medicine,9 bioimaging,10 sensing11,12 and 
catalysis.13,14 Among them, the controlled assembly of polymers and/or proteins via 
supramolecular interactions offers unique opportunity in understanding the spontaneously 
self-organization process and fabrication of bioactive PNPs.15–21 Currently PNPs are 
usually prepared using standard bulk reaction conditions,22–26 which generally lead to large 
variability in their size distribution. In fact, it remains difficult to reproducibly synthesize 
batches of homogenous PNPs in bulk reactors, primarily due to the uncontrolled and 
insufficient mixing in addition to the uncontrolled residence time during the PNPs 
formation.27 Therefore, methods that provide precise control of PNPs size distribution (for 
example, through microfluidics by optimizing mass transfer kinetics and diffusion rates, 
etc.) are of high interests.28–30 
In our previous work, we systematically studied the co-assembly of poly(4-
vinylpuridine) (P4VP) or other pyridine group grafted polymers with functional proteins 
to form core-shell PNPs.21,31–34 The synthesis involved the mixing of polymer with protein 
in bulk reactors to form NPs intermediates, followed by dialysis or organic solvent 
evaporation for NPs maturation (Figure 3.1a). The assembly is primarily controlled by a 
kinetic process driven by the reduction of interfacial tension, i.e., the polymer forms 
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aggregates when experiencing non-solvents. After this nucleation step, proteins, acting as 
a surfactant-like role, are absorbed on the surface to stabilize the NPs. We hypothesize the 
protein is a relative slower step compared to the fast nucleation during the co-assembly. 
Both the fine balance between hydrophobicity and hydrophilicity as well as the hydrogen 
bonding between proteins and polymers are necessary for a successful co-assembly.21 
Nevertheless, because of the insufficient and less controllable mixing in bulk reactors, the 
polymer and polymer-protein particles experienced heterogeneous solvent environment 
during co-assembly, resulting in a broad size distribution of the NPs.21,31,33 
 
Figure 3.1 (a) Schematic illustration of proposed polymer-protein co-assembly process. 
(b) Schematic illustration of the entrance of microchannel which is used for polymer 
protein co-assembly. The fluids with different electrical conductivity (σ1 & σ2) in the non-
parallel microchannel are driven by the hydrodynamic force fh and the flow is excited by 
the electrical body force fe which can be divided into x-components fex and y-component 
fey. fex at different points along the electric line can be either negative or positive related to 
fh. The large force in x-direction (fh + fex) and y-direction fey can generate a shear stress and 
produce a micro vertex,38 resulting in ultrafast mixing. 
Using microfluidics based microreactor to synthesize various functional 
nanoparticles has attracted attentions because of its unique advantages, such as controllable 
transportation at microscale, significantly reduced diffusion distance, etc.35 With improved 
diffusion process via geometrical design, microfluidics based mixers have been used for 
synthetic purposes.29,36,37 However, because normally Reynolds number is low in 
microfluidic devices, the flow is laminar and the corresponding mixing is conducted only 
through a molecular diffusion process, and thus is relatively slow and poor. For this reason, 
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Dr. Guiren Wang’s group has developed a method to generate turbulent-like flows to create 
ultrafast mixing in microfluidic system under electrokinetics (EK) forcing,38,39 which 
provides new opportunities for flow control and manipulation in microfluidics. In 
particular, it was found that rapid mixing could be achieved on both large and small scales 
in the majority of the microchannel under AC electric field.38 For example, with a 20 Vp-p 
voltage and 2 μL/min flow rate, 77% mixing can be reached within 5 milliseconds (ms),40 
which is much faster than other reported EK based micromixers.41,42 Moreover, the mixing 
process could be easily controlled and fine-tuned by adjusting the AC electric fields (e.g. 
voltage, frequency, signal phase shift) and flow rates,43 which makes it a superior technique 
than conventional geometry based micro mixers regarding to controllable mixing 
manipulation. 
Herein, for the first time, we report the usage of this EK based microfluidic method 
(Figure 3.1b) to achieve polymer-protein co-assembly in order to fabricate homogeneous 
polymer-protein nanoparticles. Nanoparticle size is the result of two competing processes: 
drop breakage and coalescence after nucleation.44 In our system, when protein stream and 
polymer dissolved ethanol stream meet in the microchannel, polymer droplets between 
the two phases of fluids will form at the initial stage and can then coalesce. The EK flow 
induced shear stress may breakup larger drops to generate smaller ones to increase 
interfacial area, and thus to enhance molecular mixing. The particle size distribution 
depends not only on the dispersive and continuous phase properties, the presence of 
surface-active agents, the type of surfactants, and the presence of electrolytes, but also on 
the overall flow velocity and concentration fields. Therefore, in this contribution, different 
proteins, flow rates and protein/polymer mass ratios were tested for the co-assembly via 
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fast mixing of micro fluids. We demonstrate that the polymer-protein NPs fabricated using 
our microfluidic method are highly uniform, the NPs size is tunable, and proteins’ function 
is well retained. Because it is much easier to scale up by parallelization of multiple channels 
compared to the bulk method, this EK-based microfluidic method has unique advantages 
in its application for polymer protein co-assembly. 
3.2. THEORY 
The principle of generating chaotic EK flow and mixing is given below to illustrate 
qualitatively how the mixing is enhanced. There is an initial large electrical force that can 
overcome viscous force to generate strong chaotic flows. The Navier-Stokes equation with 
EK force can be described as 
𝜌(𝜕𝑢 𝜕𝑡⁄ + 𝑢 ∙ 𝛻𝑢) = 𝛻𝑝 + 𝜇𝛻2𝑢 + 𝐹𝑒   (1) 
𝐹𝑒 =  𝜌𝑓𝐸 −
1
2
(𝐸 ∙ 𝐸)∇𝜀 +
1
2
 ∇ [𝜌𝐸 ∙ 𝐸 (
𝜕𝜀
𝜕𝜌
) 𝑇]  (2) 
𝜌
𝑓
= ∇ ∙ (𝜀𝐸) = ∇𝜀 ∙ 𝐸 + 𝜀∇ ∙ 𝐸    (3) 
where ρ, 𝑢 , p, μ are the fluid density, flow velocity, pressure and dynamic viscosity 
respectively; 𝐹𝑒 is electrical body force, which consists of the Coulomb force (1
st term), 
dielectric force (2nd term) and thermal expansion (3rd term) respectively in Eq. (2); 𝐸 is 
electric field, 𝜌𝑓 is the free volume charge density; 𝜀 and σ are the electric permittivity and 
conductivity of the electrolyte respectively, and T indicates temperature. For 
incompressible fluids, the third term can generally be ignored.45 In addition, for a given 
fluid, 𝜀 mainly depends on T. On the one hand, as the two initial streams with different 
conductivity σ meet together, the interface between the two streams can be assumed to be 
frozen within a very short distance before the electrokinetic flow starts to develop. On the 
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other hand, the bulk flow and the generated strong mixing will also transfer potential heat 
caused by Joule heating to downstream and to the good heat conductive metal walls. 
Therefore, T variation due to electrothermal effects could be insignificant. Thus 𝜀  is 
assumed to be uniform in the flow, 𝜕𝜀 𝜕𝑡⁄ ≈ 0 and ∇𝜀 ≈ 0. So the second term force in 
Eq. (2) is also negligible. Then we have 
𝐹𝑒 = 𝜌𝑓𝐸  (4) 
The transport equation of 𝜌
𝑓
 for a bipolar system is: 45 
𝜕𝜌𝑓
𝜕𝑡
+ 𝑢 ∙ ∇𝜌
𝑓
+ ∇ ∙ (𝜎𝐸) = (
𝐷+−𝐷−
𝑚++𝑚−





  (5) 
where 𝜎 is the conductivity of the fluid, 𝑚+ and 𝑚−and  𝐷+ and 𝐷− are the mobility and 
diffusivity of positive and negative charges respectively. Since in liquid, Schmidt number 
is usually very large, to simplify the process to illustrate the major physics, the diffusion 
term can be negligible. Because of the large conductivity different between the two 
streams, 𝐸  will generate  𝜌𝑓  near the interface, and the transport of 𝜌𝑓 is primarily 




𝜕𝑡⁄ + ∇ ∙ (𝜎𝐸) = 0  (6) 
Note although based on electro neutrality assumption, which is often adopted for transport 
phenomena in electrolyte, ∇ ∙ (𝜎𝐸) = 0, such an approximation is not applicable here, not 
only because the well-known reasons described by Probstein,46 but also because of the 𝜌
𝑓
 
created at the interface with a large difference in the conductivity between the two streams 
70 
as shown in Fig 3.1b. Near the interface, 𝜌
𝑓
 should not be zero, as 𝐸 has also a large 
difference at the interface between the initial two streams. The large difference in 𝐸 is due 
to the difference in 𝜎, which in turn generates 𝜌
𝑓
 under local 𝐸. Substitution of Eq. (3) into 
(6), yields: 
∇ ∙ 𝐸 ≈ − (∇𝜎 ∙ 𝐸 + 𝜀∇ ∙
𝜕𝑬
𝜕𝑡
) 𝜎⁄   (7) 
Substituting Eq. (7) back into Eq. (4) and (3), we find that the initial 𝐹𝑒  can be 










) 𝐸  (8) 
Here the first term of Eq. (8) is consistent with the result in DC case,47 the second term is 
related to the initial 𝐹𝑒 due to AC 𝐸. However, in practice, to satisfy quasi-electrostatic 
condition, normally 
𝜀𝑟𝑒𝑓𝜔 < 𝜎1 < 𝜎2 − 𝜎1  (9) 
where σ1 and σ2 are σ of the stream 1 and 2 respectively. Then the 2nd term of Eq. (8) 




𝐸  (10) 
Eq. (10) indicates that 𝐹𝑒  increases with increasing ∇𝜎  and 𝐸 , and parallelizing them. 
Initially, at a large scale where the influence of fluid viscosity is small, 𝐹𝑒  directly drives 
and causes strong chaotic EK flow. The order of the corresponding velocity can be reached 
by balancing the inertial term and 𝐹𝑒 in Eq. (1) as 
𝑈𝑒 = √𝜀𝑟𝑒𝑓(𝜎2 − 𝜎1) 𝐸0
2/ 𝜌𝜎1   (11) 
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At a specific length scale l, where the time scale of convection under forcing (𝜏𝑒  = 𝑙 𝑈𝑒⁄ ) 
is equal to the corresponding viscous diffusion time scale (𝜏𝑑 = 𝜌𝑙
2 𝜇⁄ ), a nominal length 
scale in the EK flow can be qualitatively concluded: 
𝑙𝑒𝑑 = √𝜇
2𝜎1 𝜌𝜀𝑟𝑒𝑓𝐸0
2(𝜎2 − 𝜎1)⁄ = √𝑤
2 𝐺𝑟𝑒⁄    (12) 
𝐺𝑟𝑒 = (𝑈𝑐𝑙 𝜈⁄ )
2  = 𝜌𝜀𝑟𝑒𝑓𝑤
2𝐸0
2(𝜎2 − 𝜎1)/𝜎1𝜇
2  (13) 
where 𝐺𝑟𝑒 is the nominal electric Grashof number. To describe the electrical conductivity 
field in Eq (10), we need transport equation for conductivity. For a bipolar system 
uniform  𝜀 , if there are neither production nor consumption of charges, the transport 
equation for conductivity is: (Melcher 1981, page 5.33) 48 
𝜕𝝈
𝜕𝑡











  (14) 
𝐷𝑒 =  
𝐷+𝑚++𝐷−𝑚−
𝑚++𝑚−
    (15) 
where 𝐷𝑒  is an effective diffusivity. The concentration of the protein and polymer is 
important for the nanoparticle synthesis. The protein in the solution is charged, but the 
polymer is not. Ignoring the chemical reaction, the transport equation of their concentration 
can be described as (Truskey et al. page 362):49 
𝜕𝑐𝑖
𝜕𝑡
+ 𝑢 ∙ ∇𝑐𝑖 = 𝐷𝑚𝑖∇
2𝑐𝑖  (16) 
𝐷𝑚𝑖 =
(𝑧+ −𝑧−)𝐷+ 𝐷−
(𝑧+ 𝐷+ −𝑧− 𝐷−)
    (17) 
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where 𝑐𝑖 is concentration of each component i, i.e. either polymer or protein, 𝑧− and 𝑧+ are 
the charge valance of protein and ions. For polymer 𝐷𝑚𝑖 is its own diffusivity, but for 
protein, 𝐷𝑚𝑖 is given in Eq. (17), where ions in buffer balance the charge of the protein. 
Let 𝑢 = 𝑈𝑐?̂?, 𝑡 = 𝜏?̂?, 𝑥 = 𝑈𝑐𝜏?̂?, ∇= ∇̂ 𝑈𝑐𝜏⁄ , 𝜎 = 𝜎0?̂?, 𝐸 = 𝐸0?̂?, 𝑝 = 𝜌𝑈𝑐
2, 𝜀 = 𝜀𝑟𝑒𝑓𝜀̂ , 












?̂?  (18) 
𝜕?̂?
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  (19) 
𝜕𝑐?̂?
𝜕?̂?





𝑐?̂?   (20) 
where ?̂? ,  ?̂? , ∇̂  and ?̂? , ?̂?,  and 𝜌
?̂?
 are dimensionless functions of 𝑢 ,  𝑥 , ∇ , 𝐸 , 𝜎  and 
𝜌
𝑓
 respectively; 𝜎0 = 𝜎2 − 𝜎1  is the initial characteristic σ of the flow; 𝐸0 = 𝑉𝑓/√2𝑤 
represents the nominal 𝐸 across the channel width 𝑤 (where Vf is the applied peak-to-peak 
voltage between two electrodes. w is the width of the channel at the entrance.). 𝜀𝑟𝑒𝑓 is the 
𝜀 of water at a reference T; 𝑆𝑐𝑒 = 𝜇 𝜌𝐷𝑒⁄  and 𝑆𝑐𝑚𝑖 = 𝜇 𝜌𝐷𝑚𝑖⁄  are Schmidt number of 
effective ions and component i respectively; τr = 𝜀/𝜎0 is charge relaxation time, Re,mig =
𝑙𝐸0(𝑚+ + 𝑚−)/𝜐 is charge migration Reynolds number, and τ𝐷 = 𝑙
2/(𝐷
+
− 𝐷−) is a 
charge diffusion time respectively. 
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If Gre is sufficiently high, e.g. by increasing initial(𝜎2 − 𝜎1), the diffusion terms 
of the right side in Eq. (18), (19) and (20) become approximately negligible. Both 
conductivity and concentration will be dispersed by 𝑈𝑒  and chaotic EK flow without 
smearing in the entire transverse direction. This can even enhance 𝐹𝑒 and thus, mixing at 
small scale to generate homogeneous ci. By increasing the initial 𝜎2 𝜎1⁄ , 𝐸0  and 
parallelizing ∇𝜎 and 𝐸, 𝐺𝑟𝑒 can be enhanced. 
3.3. EXPERIMENTAL DETAILS 
3.3.1. MICROCHANNEL FABRICATION 
The design and fabrication of the microchannel is shown in Figure 3.2 in 
supporting information. A quasi T-shaped microchannel was made of acrylic plates, gold 
chips, Teflon™ PFA membrane, Teflon™ PTFE sheets and gasket by lamination-based 
microfabrication.38 Gold chips were used as electrodes to make the two electrically 
conductive channel sidewalls. Teflon™ PFA membranes were used to avoid the channel 
clogging problems caused by the high stickiness of polymer, which has been one of the 
major obstacles in microfluidic nanomaterials synthesis.50 A Teflon™ PTFE splitter plate 
was used to separate the two steams initially till they meet in the microchannel and lead to 
a sharp interface with high conductivity gradient between the two streams, which can 
further enhance the mixing efficiency. The microchannel has a rectangular cross-section of 
150 μm in width at the entrance and 230 μm in height, with the length of 5 mm. A small 
divergent angle of 5° was designed to maximize the mixing efficiency (Figure 3.1b, 
3.2b).38 Rubbers were used to seal the channel. Because of the rapid polymer protein co-
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assembly process under the ultrafast mixing, no significant polymer aggregates or other 
clotting issues were observed during the NPs fabrication with our microfluidic channel. 
 
Figure 3.2 Schematic of the microchannel design and fabrication (a) and the image of 
microchannel near the entrance (b). 
3.3.2. MATERIALS 
Teflon™ PFA membrane, Teflon™ PTFE sheets were purchased from 
Cshyde. Gold chips were purchased from Surepure Chemetals. Fluorescein sodium 
salt, P4VP (Mw 60000), p-aminophenol (pAP, >99.0%) were purchased from 
Sigma-Aldrich. Phenazine methosulfate (PMS, >98.0%) was purchased from TCI 
America. NADH sodium salt was purchased from EMD Millipore. Unless otherwise 
noted, all chemicals and solvents used were of analytical grade and were used as 
received from commercial sources. Water (18.2 MΩ) was obtained from Milli-Q 
system (Millipore). The proteins used in this work include bovine serum albumin 
(BSA) (MW: 66 kDa, pI: 4.7), fluorescent protein EGFP (MW: 27 kDa, pI:5.6) 
fluorescent protein mCherry (Mw: 29 kDa, pI: 5.6), N-oxygenase CmlI (Mw: 38 
kDa, pI: 5.0). BSA was purchased from Sigma-Aldrich. All other proteins were 
expressed in E. coli BL21 (DE3) in LB medium, and purified by nickel-nitriloacetic 
acid (Ni-NTA) affinity chromatography as described previously.51,52. PBS buffer 
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(NaCl 137 mM, KCl 2.7 mM, Na2HPO4 10 mM, KH2PO4 1.8 mM, pH 7.4) was used 
unless otherwise noted. 
3.3.3. FLOW VISUALIZATION 
The microchannel was placed on an inverted fluorescent microscope 
(Olympus-IX70). Solutions injection was done by a syringe pump (Harvard, Model 
PHD2000 Programmable) with different flow rates. AC electric power was supplied 
by a function generator (Tektronix, Model AFG3102). The visualization of the 
mixing process was conducted by Epi-fluorescence imaging technique. 
3.3.4. POLYMER-PROTEIN CO-ASSEMBLY 
For P4VP protein(s) co-assembly with microfluidic method, P4VP dissolved 
in ethanol and protein(s) dissolved in PBS were injected by two different size of 
syringes (1 mL vs 10 mL). The syringe pump was used to control flow rates. AC 
electric power was supplied by the function generator to provide electric field. 20 
Vp-p voltage, 20 kHz frequency, 180° phase shift were used unless otherwise noted. For 
P4VP-protein(s) co-assembly with conventional bulk method, 100 μL of P4VP 
dissolved in ethanol was added into a glass vial containing 1mL protein(s) dissolved 
in PBS buffer drop wisely during vigorous magnetic stirring. The concentration of 
P4VP and proteins solution was adjusted as the same among different methods. 
More than three batches of assembled samples were collected under each condition 
for characterization unless otherwise noted.  
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3.3.5. POLYMER-PROTEIN NPS CHARACTERIZATION 
The hydrodynamic size distribution of nanoparticles was measured by 
Zetasizer (Nano ZS, Malvern Instruments). The mean value for the size based on the 
intensity, and the PDI, a dimensionless width parameter based on the cumulants 
analysis, were reported. For TEM analysis, the NPs samples were diluted 5 times by 
DI water, 20 μL diluted sample was dropped onto 250-mesh carbon-coated copper 
grids. The grids were dried, washed once by DI water and observed with a Hitachi 
H-8000 electron microscope. NPs size and size distribution based on TEM images 
were analyzed by ImageJ software. 
For protein (BSA as the model protein) loading efficiency characterization, 
the NPs samples were centrifuged at 9 K rcf for 10 min at room temperature, the 
supernatants were collected for a standard Bradford assay. The loading efficiency 
on the NPs was calculated from the unbound proteins in the supernatant by 
subtracting the amount of the unbound proteins from the initial amount of proteins 
used. 
For fluorescence imaging of polymer fluorescent protein(s) NPs, glass 
coverslips and plates were first soaked in a 10:1 (v:v) mixture of concentrated H2SO4 
and 30% H2O2 overnight, extensively rinsed with water, sonicated in absolute 
ethanol for 10 mins and dried with air stream. The NPs samples after centrifuge were 
dispersed on the cleaned plates covered by a coverslip and sealed by nail polish oil. 
A self-assembled confocal microscope with an oil immersion, 60× NA1.4 and 
PlanApo objective lens (Olympus). A continuous wave laser (477 nm, 100 µW), 
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filter cubes/sets and a photomultiplier tube (PMT, HAMAMATSU, R-928) were 
used. 
CmlI catalyzed reactions with pAP were measured by monitoring p-nitroso 
phenol (pNOP) product formation at an absorbance of 405 nm with a Molecular 
Device SPECTRAMax plus 384 with a microplate reader using 0.33 cm path length. 
Since CmlI enzyme is tolerant to ethanol,51 no ethanol evaporation or dialysis was 
done for P4VP-CmlI NPs sample. Instead, the assembled samples were used for 
activity test directly without purification. For different samples, the same amount of 
free enzyme and the same percentage of ethanol (9.1%) were used. 
3.3.6. CONDUCTIVITY AND VISCOSITY TEST 
A conductivity meter (EXTECH ISTRUMENTS, ExStik II) was used for 
conductivity test. Viscosity was tested by Cannon-Ubbelohde Viscosity meter, #25. 
3.4. RESULT AND DISCUSSION 
3.4.1. MIXING VISUALIZATION 
To demonstrate the EK-based fast mixing process, a modified quasi T-shaped 
microchannel was fabricated as shown in Figure. 3.2. Teflon materials were used to 
coat the inner faces of the microchannel in order to avoid the clotting problems. Firstly, 
fluorescein in PBS was mixed with deionized (DI) water using our microfluidic 
system. The conductivity ratio of these two streams was 5000:1. Different flow rates 
from 1 to 10 μL/min were tested (Figure 3.3). In the absence of electric field, 
laminar flows were formed in the microchannel, and only some diffusion could be 
observed with slower flow rate (Figure 3.3a). The boundary of the fluorescein 
solution and PBS solution was blurred with 1 μL/min flow rate and became much 
78 
clearer with higher flow rates (≥2 μL/min, Figure 3.3c, 3.3e, 3.3g). While under 
electric field, chaotic flows were formed, which demonstrated dramatically 
enhanced mixing (Figure 3.3b, 3.3d, 3.3f, 3.3h). Thus, significant increased 
diffusion is expected. A similar phenomenon was also observed with EGFP solution 
and polymer solution as injected as the two streams with ratio of ~ 6400: 1 (17260 
µS/cm vs2.7 µS/cm) (Figure 3.4). Since the flow rate of EGFP solution was much larger 
than that of the polymer solution, EGFP solution occupied the most space of the channel 
and the boundary moved to the polymer side significantly. The boundary was still visible, 
although it was less clear. In the absence of electric field, the laminar flow pattern depends 
on the Peclet number (Pe), which is determined by the flow rate for certain micro flows, 
and the ratio of the flow rate of the two streams.51,52 The larger the Pe, the clearer the 
boundary of the two streams. For flow rates of 1 μL/min (in Figure. 3.4a) or lower, the 
molecular diffusion in transverse direction becomes more important, and a less clear 
interface was seen. A clearer boundary was observed when higher flow rates (≥2 μL/min) 
were used as shown in Figure4c, 4e, 4g. Considering the much higher viscosity of 
P4VP polymer solution than that of DI water (2.1 mm2/s vs. 1.0 mm2/s), we can 
conclude that the mixing under electric field is highly robust in this microfluidic 
channel. It is worthy to note that, with a 10 μL/min flow rate, highly homogeneous 
mixture of EGFP solution and P4VP solution can also be achieved at around 150 
μm downstream of the entrance under electric field (Figure 4.4h), which implies a 
complete mixing starting from this position. 
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Figure 3.3 Visualization of mixing process with fluorescein in PBS and DI water 
with different flow rate. a, c, e, g: laminar flow without electric field. b, d, f, h: 
chaotic flow with electric field. The top stream is dye solution; the bottom stream is 
DI water. Two 1 mL syringes were used for injection. 7 Vp-p is used. 20 Vp-p 20 
kHz frequency, 180° phase shift are used. 0.015 s exposure is used during the 
imaging. 
 
Figure 3.4 Visualization of mixing process with EGFP protein in PBS and P4VP in 
ethanol with different flow rates. a, c, e, g: laminar flow without electric field. b, d, 
f, h: chaotic flow with electric field The top stream is EGFP solution, which is 
injected by 1 mL syringe. The bottom stream is P4VP solution, which is injected by 
10 mL syringe. 20 Vp-p 20 kHz frequency, 180° phase shift are used. 0.015 s 
exposure is used during the imaging. The red arrows show the small fractions of 
polymer solution in the channel. 
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3.4.2. IMPROVED SIZE DISTRIBUTION OF POLYMER-PROTEIN NPS VIA 
MICROFLUIDIC METHOD 
Firstly, BSA was used as a model protein to fabricate P4VP-protein NPs in 
this microfluidic method. Proteins were dissolved in PBS buffer (0.05 μg/μL), and 
P4VP was dissolved in ethanol (0.5 μg/μL). Flow rates 2 μL/min, 5 μL/min and 10 
μL/min were tested while the electric field condition was kept the same. Mass ratio 
of P4VP to BSA was fixed as 1:1 (the volume ratio VP4VP:VBSA = 10:1). 
Transmission electron microscopy (TEM) and Dynamic light scattering (DLS) 
analysis shows that the size distribution of NPs produced by microfluidics is 
significantly improved by comparing with the samples from conventional bulk 
method (Figure 3.5). More TEM) images of NPs demonstrate further that highly 
homogeneous NPs can be fabricated by microfluidic method compared to the 
conventional bulk method ((Figure 3.6). Size distribution of NPs at different areas 
of TEM grids was analyzed (Figure 3.6e, 3.6j, 3.6o). With higher flow rates, the 
polydispersity index (PDI) of NPs is slightly increased, likely due to the reduced 
mixing in the channel. On the other hand, if there was no electric field applied, much 
larger and inhomogeneous NPs (average size as 680 to 770 nm depending on flow 
rates) were produced, and large amount of polymer aggregates could be observed 
under TEM (Figure 3.7). Within the enhanced chaotic flows, proteins and polymer 
precursors can be well mixed in a very short time by increased shear stress. We 
postulate that during the co-assembly in micro flows under an AC electric field, the 
size of NPs and local concentration of the starting materials in the mixture can be 
balanced. Thus, continuous aggregation of unassembled polymers is suppressed. 
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Additionally, the residence time distribution (RTD) of the assemblies is narrowed, 
which is ultimately responsible for the improved NPs’ homogeneity. 
 
Figure 3.5 Size and size distribution of P4VP-BSA NPs fabricated by microfluidics at 
different flow rates and conventional stirring method. (A-D): TEM image of nanoparticles 
by microfluidics with 2 μL/min (a), 5 μL/min (b), 10 μL/min (c) and stirring method (d). 
(e), (f): DLS analysis of nanoparticles by different methods. Final concertation of P4VP 
0.05 mg/mL, BSA 0.05 mg/mL for all samples. Error bar stands for standard deviation of 
three replicates. 
 
Figure 3.6 Representative TEM images of P4VP-BSA nanoparticles fabricated by 
microfluidics with 2 μL/min (a-d), 10 μL/min (f-i) flow rates, and bulk method (k-n). Scale 
bars: 0.5 μm. (e, j, o) Statistical analysis of the NPs size and distribution. The red curves 
are Gaussian fits to the corresponding histograms. For all samples, 0.05 mg/mL P4VP and 
0.05 mg/mL BSA were used as final concentration.  
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3.4.3 THE SIZE OF POLYMER-PROTEIN NPS IS TUNABLE 
Our previous works showed that, driven by the interfacial energy, the surface 
composition and materials’ concentration could influence the size of the P4VP-
protein NPs.21,32 When the mass ratios of polymer to protein were adjusted as 1:8, 
1:0.8 and 1:0.08 for the two streams in the microchannel, different size of NPs were 
fabricated with 2 μL/min flow rate. TEM images and DLS analysis show that the 
size of fabricated NPs increases with the increase of the polymer/protein mass ratio 
(Figure 3.8a-d). The average hydrodynamic sizes are 284 nm, 523 nm and 925 nm 
with polymer/protein ratio as 1:0.8, 1:0.08 and 1:0.008, respectively. Again, by 
comparing with the NPs produced by conventional bulk method, the size 
distributions of NPs fabricated through microfluidics were significantly improved 
(Figure 3.8e and Figure 3.9a-d). While the NPs fabricated by microfluidic method 
are stable at room temperature (Figure 3.8f), the size of NPs prepared by 
conventional bulk method shows growth within 3 days’ incubation at room 
temperature, especially when high polymer/protein ratio was used (Figure 3.8e), we 
rationalize that it was caused by the agglomeration of polymers and NPs due to 
scattered protein coating on the surface of NPs.31,33 The sustained size and 
morphology of NPs during the ethanol evaporation as well as long-term storage at 4 
oC indicate that mature and stable polymer protein NPs have been formed via 
microfluidic co-assembly (Figure 3.10). The interactions between polymer and 
proteins and the benign microenvironment provided by polymers likely contribute 
to the stability of the enzyme and the resultant assemblies. The protein loading 
efficiencies of NPs fabricated with the microfluidic method under different 
conditions (with 2 μL/min to 10 μL/min flow rates and 1:1 to 1:10 polymer/protein 
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mass ratios) were measured (Figure 3.11). They were around 70%, demonstrating a 
good protein loading capacity using this microfluidic method. Interestingly, if the 
entrance width of the channel is decreased into 90 μm, much smaller NPs can be 
fabricated, nevertheless the NPs size cannot be well-controlled by adjusting 
polymer/protein mass ratio anymore (Figure 3.12). We believe that the matching of 
mixing time and co-assembly time is critical to control the size of final NPs. With 
further increasing mixing intensity, the NPs size could be insensitive to the starting 
materials ratio. Similar phenomenon has been reported for self-assembly of 
copolymeric NPs.53 
 
Figure 3.7 TEM images of P4VP-BSA nanoparticles prepared by microfluidic 
method without electric field with 2 μL/min (a), 5 μL/min (b), 10 μL/min (c) flow 
rate, and the DLS test (d). Final concentration as P4VP 0.05 mg/mL, BSA 0.05 
mg/mL. The result is consistent with DLS test, which confirm the role of EK based 
mixing contribute to the NPs’ size and size distribution. Scale bar: 1 μm. 
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Figure 3.8 Different size of P4VP-BSA NPs fabricated by adjusting polymer/protein ratio 
and the stability test. (a-c) Representative TEM images of P4VP-BSA with different size 
fabricated by microfluidics. Scale bars represent 0.5 μm. (d) DLS analysis of different size 
of NPs fabricated by microfluidics. (e) PDI comparison of the NPs fabricated by 
microfluidics and conventional bulk method. **P-value < 0.01, *P-value < 0.05 by 
Student’s t-test. (f) Average hydrodynamic size of NPs fabricated by microfluidics with 
different aging time at room temperature as detected by DLS. A fixed concentration of 0.05 
mg/mL was used for P4VP, while BSA was adjusted from 0.4 mg/mL to 0.04 mg/mL to 
0.004 mg/mL for the fabrication of small, medium, and large size NPs. Error bar stands for 
standard deviation of triplicate samples. 
 
Figure 3.9 P4VP-BSA NPs prepared by conversional dropwise and stirring method and 
thermostability test. The average size of NPs can be adjusted by protein/polymer ratio. (a-
c) Representative TEM images of P4VP-BSA with different average size. (d) DLS 
measurement of the NPs with the polydispersity index as 0.20, 0.14, and 0.39, respectively. 
0.05 mg/mL P4VP was used for all sample, BSA was used as 0.4 mg/mL, 0.04 mg/mL and 
0.004 mg/mL for different size of nanoparticles. (e) Average hydrodynamic size of NPs 
with time going at room temperature, which was detected by DLS. 
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Figure 3.10 TEM images of P4VP-BSA nanoparticles prepared by microfluidics with 
storing at 4 °C for 30 days (a-c) and during ethanol evaporation. Flow rate was with 2 
μL/min (a), 5 μL/min (b), 10 μL/min (c-f). Final concertation of P4VP 0.05 mg/mL, BSA 
0.05 mg/mL for all samples. (d) Samples without evaporation (with 10% ethanol), (e) 
samples with 50% volume evaporation (with <5% ethanol left), and (f) samples with 90% 
volume evaporation (with <1% ethanol left). No much difference was observed among the 
samples during ethanol evaporation, which implies a stable nanostructure. Evaporation was 
done at 45 °C heating block. Scale bars: 1 μm. 
 
Figure 3.11 Loading efficiency test with P4VP-BSA NPs fabricated with different 
methods: Different flow rates (2 μL/min, 5 μL/min and 10 μL/min) were tested for 
microfluidic method. Final concentration of P4VP was 0.05 mg/mL for all samples. Error 




Figure 3.12 DLS analysis of P4VP-BSA nanoparticles (a) prepared by a different 
microchannel with 90 μm width at the channel entrance, and other dimensions were kept 
the same (b). For all samples, 0.05 mg/mL P4VP was used, and 0.5 mg/mL and 0.05 mg/mL 
BSA were used, respectively. For EK-based microfluidics control, 20 Vp-p, 20 kHz 
frequency, 180° phase shift are used. 
3.4.4. POLYMER-FLUORESCENT PROTEINS CO-ASSEMBLY AND FUNCTION 
TEST 
To characterize the structural change of NPs fabricated by microfluidic 
method, EGFP and another fluorescent protein mCherry (or BSA) were used to co-
assemble with P4VP polymer to produce polymer multi-protein NPs P4VP-EGFP-
mCherry and P4VP-EGFP-BSA. Mass ratio of polymer/EGFP/mCherry (or BSA) 
was fixed as 4:1:1. The BSA was used in the P4VP-EGFP-BSA to balance the 
polymer protein ratio to control the NPs size. TEM imaging reveals that the 
homogeneous polymer proteins NPs were fabricated successfully by microfluidic 
method (Figure 3.13). Fluorescence images of P4VP-EGFP-mCherry and P4VP-
EGFP-BSA NPs were taken by a laser scanning confocal microscopy (Figure 3.14). 
This laser is suitable to excite EGFP and minimize the ‘cross talk’ signal from 
mCherry simultaneously (P4VP-mCherry-BSA NPs cannot be detected, data not 
shown). Both P4VP-EGFP-mCherry and P4VP-EGFP-BSA NPs showed bright 
signals in green channel. By excluding the effect of EGFP ‘leaking’ signal in red 
channel and the minimal ‘cross-talk’ signal from mCherry, the red/green signal 
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intensity ratio was calculated for P4VP-EGFP-mCherry and P4VP-EGFP-BSA 
single NPs to show an apparent fluorescence resonance energy transfer (FRET). The 
red/green signal intensity ratio of P4VP-EGFP- mCherry is much higher than that 
of P4VP-EGFP-BSA (~two-fold changes, Figure 3.14g), which reveals significant 
FRET occurring between the assembled EGFP and mCherry on the NPs. This result 
not only demonstrates the function of both fluorescent proteins still sustained but 
also implies a very closed distance between the two proteins on the NPs, which could 
be potentially used for bio-imaging applications.54 
 
Figure 3.13 TEM images of P4VP-EGFP-BSA (a), P4VP-EGFP-mCherry prepared by 
microfluidic method with 10 μL/min (b) and conventional stirring method (c). Mass ratio 
of P4VP: total proteins = 2:1. P4VP-CmlI NPs prepared by conventional stirring method 
(d). For assembly,.0.25 mg/mL P4VP, 1.1 mg/mL CmlI were used.  
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Figure 3.14 Function characterization of P4VP-protein(s) NPs prepared by microfluidic 
method. Fluorescence microscopy images of P4VP-EGFP-mCherry (a-c), P4VP-EGFP-
BSA (d-f) show the sustained fluorescence protein(s) function on NPs and a significant 
FRET effect (insets). Scale bars: 5 μm. Insets: representative image of single P4VP-EGFP-
BSA and P4VP-EGFP-mCherry NP; Scale bars: 500 nm. (g) Signal intensity ratio of Red 
to green channels of P4VP-EGFP-mCherry and P4VP-EGFP-BSA prepared by 
microfluidic method. Error bar stands for standard deviation of ten single nanoparticles of 
each samples. For co-assembly, 0.05 mg/mL P4VP, 0.0125 mg/mL EGFP, 0.0125 mg/mL 
mCherry or 0.0125 mg/mL BSA and 2 μL/min flow rate were used. 
3.4.5. POLYMER-ENZYME CO-ASSEMBLY AND ACTIVITY TEST 
To further evaluate the sustained protein function on the NPs, an N-
oxygenase CmlI55 was used as a model enzyme to co-assemble with P4VP polymer 
by microfluidic and conventional bulk method (as reported previously).51 TEM 
image reveals highly uniform P4VP-CmlI NPs fabricated by this microfluidic 
method (Figure 3.15a). It is worth to note that the homogeneity of P4VP-CmlI NPs 
is slightly better than other P4VP-proteins NPs by using microfluidic method, which 
could be attributed to multiple factors including protein’s MW, surface charge and 
hydrophobicity and others. More systematic study will be needed to understand this 
difference. CmlI enzyme activity can be determined by a p-nitrosophenol (pNOP) 
based chromogenic assay with presence of p-aminophenol (pAP) as substrate, 
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nicotinamide adenine dinucleotide (NADH) as electron source and phenazine 
mediator (Figure 3.15a inset).51 By comparing with the activity with the same 
amount of free enzyme, P4VP-CmlI NPs from either microfluidic method or bulk 
method show slightly higher activity than the free enzyme (Figure 3.15b), which 
can be attributed to the faster electron transferring process upon polymer assembly.51 
This result confirms that CmlI enzyme function can be fully maintained after co-
assembly with P4VP using the microfluidic system. 
 
Figure 3.15 (a) Representative TEM image of P4VP-CmlI NPs generated by microfluidic 
method and the chromogenic reaction scheme (inset), which can be used to characterize 
the polymer-enzyme NPs’ activity. Flow rate 2 μL/min was used for NPs preparation. Scale 
bar: 200 nm. (b) The chromogenic reaction shows that P4VP-CmlI NPs from microfluidic 
method have enzyme function fully sustained. Flow rate 10 μL/min was used for the NPs 
sample production. For co-assembly in both microfluidic method and stirring method 0.25 
mg/mL P4VP, 1.1 mg/mL CmlI were used. For the chromogenic activity assay 1 mM pAP, 
2 mM NADH, 40 μM PMS were used. 
3.5. CONCLUSION 
In this work, we described an EK-based microfluidic method to fabricate functional 
polymer-protein(s) NPs. The principle of fast mixing in the microchannel was illustrated 
qualitatively. Experimentally, we identified the size distribution of NPs fabricated by this 
microfluidic method could be significantly improved by comparing to that prepared by 
conventional bulk method due to the fast mixing process. The NPs size could be controlled 
by adjusting polymer/proteins ratio in the microchannel. More importantly, the 
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functionality of proteins coated were sustained. Overall, this EK-based microfluidic 
method displayed great advantages to fabricate functional nanoparticles, which could be 
potentially used in nanoparticle preparation applications in the future. 
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CHAPTER 4 




Conversion of aliphatic carboxylic acids (e.g. fatty acids) into fuels and 
platform chemicals represents a sustainable strategy in chemical industry. Despite 
the success of current chemical methodologies in the decarboxylation of aliphatic 
carboxylic acids,1–3 the required harsh conditions and high loadings of precious 
metal catalysts imply a high environmental impact. Therefore, a biocatalytic process 
at mild condition would be a viable alternative.4,5 Although some enzymes that 
utilize iron-containing cofactors to active O2 or H2O2 for the transformation of Cn 
fatty aldehyde or fatty acids to Cn-1 alkenes have been reported recently,
6–9 the 
relatively sluggish catalytic efficiencies of the native enzymes limit their practical 
applications. 
Recently, increasing attentions have been given to a group of cytochrome 
P450s from the CYP152 family named OleT, which catalyses the oxidative 
decarboxylation of fatty acids to form terminal olefins.10–12 This single-step reaction 
provides a route for drop-in fuel production from an abundant natural resource. After 
the discovery of OleTJE from Jeotgalicoccus sp. 8456 by Rude and co-workers in 
2011,10 collective efforts have been placed to understand this biocatalyst and the 
unique decarboxylation pathways. With H2O2 as a co-factor,
13 the highly reactive 
and remarkably stable intermediates compound I14 and compound II15 can be 
generated to achieve decarboxylation instead of the oxygen rebound producing 
hydroxylated products. Therefore, H2O2 has served as a desirable attribute for 
industrial transformations because of its low cost and easily scalability. On the other 
hand, the H2O2 dependent decarboxylation is highly inefficient compared to most 
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O2 dependent CYPs, primarily due to the potential for oxidative modification of 
heme prosthetic group.16 To overcome this limitation, different strategies including 
protein engineering,17 photochemistry18 and process engineering19 that generate 
H2O2 in a controlled manner have been reported. Very recently, a functional ortholog 
from Staphylococcus aureus, OleTSA, was characterized by Thomas Makris and 
others that possesses improved features including enhanced solubility and high 
stability.20,21 These features enable this ortholog to be a promising candidate for 
synthesis applications. 
Similar to many other P450s, OleT has been demonstrated to accommodate 
a broad range of substrates including different fatty acids and non-native substrates 
with a diverse size distribution and structure variation.11,22 Based on site-directed 
mutagenesis studies, small alterations of the local microenvironment23,24 can be 
translated into its reactivity. Interestingly enough, the C-C bond cleavage in OleT 
can be regulated by modifications of the enzyme F-G loop that is 17 Å from the 
active site, reflecting a flexible substrate pocket which can impart effect on its 
catalysis.20,25 In addition, cooperative binding of different compounds with other 
P450 enzymes26–29 and multiple substrates binding in the enzyme active center30 
have been experimentally investigated by many groups. Therefore, we envisioned 
that the application of appropriate small molecules to access the OleT enzyme active 
pocket may be a promising direction to leverage its catalysis efficiency. 
The fatty acid binding pocket in OleT demonstrates a highly hydrophobic 
feature. Particularly, hydrophobic residues including Phe46, Phe294, Phe79, 
Phe173, Phe291, Phe246, Phe296, Val292, Pro246, Ile170 serve as a ‘hydrophobic 
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cage’ for the fatty acid substrate in OleTJE,
22,31 which are also highly conserved in 
OleTSA.
20 Wang and co-workers reported that only meagre or no activity 
improvement was observed with the mutation of Phe to Ala near both substrate 
entrance and the active site suggesting steric hindrance has minor impact during the 
catalysis.22 We hypothesize that nonpolar small molecules have chances to access 
the enzyme hydrophobic pocket and influence the catalysis. To test this hypothesis, 
a list of small molecules was synthesized, and the OleT enzyme catalytic activity 
was analysed in the presence and absence of these small molecules. Our results 
showed that these molecules could enter the enzyme active center and affect the 
heme spin state. Interestingly, some of these molecules could augment the enzymatic 
activity of OleT. The enhanced effect of these molecules is more prominent when 
high concentration of H2O2 was used to active the enzyme. And if an H2O2 gradual 
releasing method was used, such as the GOx method as described in Chapter 2, the 
enhanced effect of the small molecules was diminished. We therefore proposed that 
the origin of the enhancement was from the enzyme oxidation step and the inhibition 
of the toxic effect due to a rapid H2O2 consumption may have played a critical role 
in this process. 
4.2 EXPERIMENTAL SECTION 
4.2.1 MATERIALS  
Eicosanoic acid (C20:0), stearic acid (C18:0), palmitic acid (C16:0), myristic acid 
(C14:0), lauric acid (C12:0), and capric acid (C10:0) were purchased from BDH 
Chemicals. The alkene standard 1-hexadecene was purchased from TCI chemicals. 
Benzene, toluene, GOx from Aspergillus niger, H2O2, hydrocinnamic acid, and 3-(4-
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bromophenyl) propionic acid were purchased from Sigma-Aldrich. D-Glucose was 
purchased from Fisher. Unless otherwise noted, all chemicals and solvents used were of 
analytical grade and were used as received from commercial sources. Unless otherwise 
noted, a solution of 200 mM K2HPO4, 100 mM NaCl, pH 7.4 was used as buffer. 
4.2.2 OLETSA ENZYME EXPRESSION AND PURIFICATION 
The protein expression and purification process is the same as that described in 
Chapter 2. Briefly, the kanamycin-resistant plasmid T5 containing a OleTSA-His6 gene was 
transformed BL21(DE3) containing the chloramphenicol-resistant pTF2 plasmid encoding 
for GroEL/GroES/Tig chaperones. A modified Terrific Broth (TB) (24 g/L yeast extract, 
12 g/L tryptone, 4 g/L peptone) supplemented with 50 μg/mL kanamycin and 20 μg/mL 
chloramphenicol was used for culturing. For protein expression, 125 mg/L thiamine, and 
trace metals, 100 μM IPTG, 10 ng/mL tetracycline and 10 mg/L of 5-aminolevulinic acid 
were added. The expression was done at 18 °C for 16-18 h. The protein was purified using 
nickel-nitriloacetic acid (Ni-NTA) affinity chromatography followed by Butyl-S-
Sepharose column polishing step as described previously. Fractions with an Rz value 
(Abs418 nm/Abs280 nm) above 1.2 were pooled and dialyzed against buffer A. Proteins 
were stored at -80 °C until further use. 
4.2.3 GENERAL PROCEDURE TO PREPARE DIFFERENT MOLECULES 
4.2.3.1 PREPARATION OF 1-PHENYL-1H-1,2,3-TRIAZOLE (MOLECULE 3) 
 
Scheme 4.1 Synthesis of molecule 3. 
100 
In an oven dried Schlenk tube, azidobenzene (1 mmol), 2-methylbut-3-yn-2-ol (1 
mmol), CuI (5 mol%), Sodium ascorbate (10 mol%) and KOH (5 mmol) were mixed in 
toluene and methanol (v/v =1:3, 8 mL) stirred at 130 °C for 2 days under argon. The 
mixture was cooled down to room temperature and purified by flash chromatography 
(hexane/ethylacetate = 10:1-3:1) to afford the corresponding product of yield 70 %.32 
4.2.3.2 PREPARATION OF 4-MONOSUBSTITUTED 1-PHENYL-1H-1,2,3-
TRIAZOLE (MOLECULE 4 AND 7) 
 
Scheme 4.2 Synthesis of molecule 4 and 7 
Azidobenzene (1 mmol) and terminal alkene (1 mmol) were mixed in water and 
ethanol (v/v =1:1, 14 mL). Sodium ascorbate (10 mol%) of freshly prepared 1 M solution 
in water was added, followed by the addition of CuSO4·5H2O (5 mol%) in water. The 
mixture was stirred overnight at room temperature. The solvent was completely removed 
and purified by column using hexane/ethyl acetate= 10:1-2:1, or DCM/methanol = 100:1-
50:1, as the eluent to afford the corresponding product. The average yields are 80-85 %.  
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4.2.3.3 PREPARATION OF N-SUBSTITUTED BENZENE SULFONAMIDE 
(MOLECULE 5) 
 
Scheme 4.3 Synthesis of molecule 5. 
To a solution of N-butylamine or N-ethylamine (4 mmol) in dry DCM (10 mL), 
triethylamine (6 mmol) was added followed by a solution of benzenesulfonyl chloride (4 
mmol) in dry DCM (10 mL) in an ice bath. The reaction mixture was stirred overnight at 
room temperature. The DCM was evaporated under reduced pressure, H2O (10 mL) was 
added, and the pH was adjusted to 2 with 1 N HCl. The product was extracted with DCM 
(3×10 mL), and the combined organic layers were concentrated under reduced pressure. 
The rude product was purified by column using Hexane/Ethyl acetate = 20:1-10:1 as eluent 
to afford the target product. The average yields were 85-88 %. 
4.2.4 SMALL MOLECULES CHARACTERIZATION 
The 1H and 13C NMR spectra were recorded at 298 K in deuterated solvents using 
Bruker Advance 400 MHz spectrometer. Data are represented as below: chemical shift, 
multiplicity (s = singlet, d = doublet, t = triplet, m = multiplet), coupling constants in Hertz 
(Hz), integration. 
1-phenyl-1H-1,2,3-trizaole (Molecule 3) 
White solid. 1H NMR (400 MHz, CDCl3): δ 8.00 (d, J = 0.1 Hz, 1 H), 7.84 (s, 1 H), 7.75-
7.72 (m, 2 H), 7.54-7.49 (m, 2 H), 7.46-7.41 (m, 1 H). 13C NMR (100 MHz, CDCl3): δ 
137.1, 134.6, 129.9, 128.9, 121.8, 120.8. HRMS: [M + H]+ m/z calcd for C8H7N3H
+: 




Figure 4.1 1H NMR spectrum of Molecule 3 
 
Figure 4.2 13C NMR spectrum of Molecule 3 
4-bultyl-1-phenyl-1H-1,2,3-triazole (Molecule 4) 
Yellow solid. 1H NMR (400 MHz, CDCl3): δ 7.71 (s, 1 H), 7.68 (d, J = 7.9 Hz, 2 H), 7.46 
(d, J = 7.7 Hz, 2 H), 7.39-7.33 (m, 1 H), 2.76 (d, J = 7.7 Hz, 2 H), 1.74-1.64 (m, 2 H), 1.46-
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1.33 (m, 2 H), 0.92 (t, J = 7.3 Hz, 3 H). 
13C NMR (100 MHz, CDCl3): δ 149.2, 137.3, 129.7, 
128.4, 120.3, 118.9, 31.5, 25.4, 22.3, 13.9. HRMS: [M + H]+ m/z calcd for C12H15N3H
+: 
202.1339, found: 202.1339 
 




Figure 4.4 13C NMR spectrum of Molecule 4 
N-butylbenzenesulfonamide (Molecule 5) 
Yellow oil. 1H NMR (400 MHz, CDCl3): δ 7.89-7.88 (m, 1 H), 7.87-7.86 (m, 1 H), 7.59-
7.55 (m, 1 H), 7.52-7.48 (m, 2 H), 4.87 (s, 1H), 2.96-2.90 (m, 2 H), 1.46-1.39 (m, 2 H), 
1.31-1.22 (m, 2 H), 0.82 (t, J = 3.2 Hz, 3 H). 
13C NMR (100 MHz, CDCl3): δ 140.0, 132.7, 
129.2, 127.1, 43.0, 31.6, 19.8, 13.6. HRMS: [M + H]+ m/z calcd for C10H15NO2SH
+: 




Figure 4.5 1H NMR spectrum of Molecule 5 
 
Figure 4.6 13C NMR spectrum of compound Molecule 5 
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N-ethylbenzenesulfonamide (Molecule 6) 
Yellow oil. 1H NMR (400 MHz, CDCl3): δ 7.89-7.88 (m, 1 H), 7.87-7.86 (m, 1 H), 7.60-
7.56 (m, 1 H), 7.54-7.49 (m, 2 H), 4.57 (s, 1 H), 3.05-2.98 (m, 2 H), 1.10 (t, J = 7.2 Hz, 3 
H). 13C NMR (100 MHz, CDCl3): δ 140.0, 132.7, 129.2, 127.2, 38.4, 15.2. HRMS: [M + 
H]+ m/z calcd for C8H11NO2SH
+: 186.0583, found: 186.0583. 
 




Figure 4.8 13C NMR spectrum of Molecule 6 
(1-phenyl-1H-1,2,3-triazole-4-yl)methanol (Molecule 7) 
Yellow oil. 1H NMR (400 MHz, DMSO-d6): δ 8.69 (s, 1 H), 7.92-7.90 (m, 2 H), 7.62-7.58 
(m, 2 H), 7.50-7.46 (m, 1 H), 5.36 (t, J = 5.6 Hz, 1 H), 4.62 (d, J = 5.7 Hz, 2 H). 
13C NMR 
(100 MHz, DMSO-d6): δ 149.7, 137.2, 130.3, 128.9, 121.5, 120.4, 55.4. HRMS: [M + H]
+ 
m/z calcd for C9H9N3OH




Figure 4.9 1H NMR spectrum of Molecule 7 
 
Figure 4.10 13C NMR spectrum of Molecule 7 
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4.2.5 UV-VIS SPECTRUM ANALYSIS 
UV-Visible spectroscopy was detected on an HP 8453 spectrophotometer. A quartz 
cuvette with 1 cm path length was used. Different OleTSA enzyme in buffer A in the 
absence and presence of small molecules was analyzed. 
4.2.6 OLETSA ENZYME ACTIVITY ASSAY 
Eicosanoic acid and stearic acid stock (10 mM) were dissolved in 70% ethanol/30% 
Triton X-100 (v:v, unless otherwise noted) as stocks. Other fatty acids including palmitic 
acid, myristic acid and lauric acid were dissolved in DMSO to make 10 mM stocks. 
Hydrocinnamic acid and 3-(4-bromophenyl) propionic acid was dissolved in DMSO to 
make a 400 mM stock. To set up enzymatic reactions, OleTSA enzyme, substrate and small 
molecule diluted into desired concentration from stocks in buffer for multiple-turnover 
reactions in a 150 μL volume. Small molecules were omitted for control reactions. 2 mM 
of H2O2 was added to initiate the reactions in H2O2 method. 300 nM of GOx was used in 
GOx method, and 6.6 mM of D-glucose was added to initiate the reactions unless otherwise 
noted. The steady-state reactions were quenched with 0.4 mM HCl or 1% acetic acid for 
GC/GC-MS or LC/LC-MS analysis, respectively. 
4.3 RESULT AND DISCUSSION 
4.3.1 SMALL MOLECULES PROFILE EXPLORED ON OLETSA CATALYSIS 
Initially benzene (1) and toluene (2) were added to the reaction of 
hydrocinnamic acid catalysed with OleTSA. As shown in Table 4.1, an enhancement 
of 14% and 20% were observed respectively in the presence of 1 mM of benzene 
and toluene. This result promoted us to further synthesize a series of small molecules 
(3-7). OleT metabolized hydrocinnamic acid reactions with and without these small 
molecules were analyzed by HPLC (Table 4.1). 
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Table 4.1 The small molecules’ effect on OleTSA activity 




 14 ± 2 
2 
 
20 ± 3 
3 
 79 ± 11 
4 
 
209 ± 23b 
5 
 
101 ± 18b 
6 
 
63 ± 5 
7 
 -6 ± 1 
a Reaction condition: 5 μM OleTSA, 2 mM H2O2, 2 mM hydrocinnamic acid, 
incubation at RT for 30 min with and without 1 mM small molecules. 
b Because OleT can further metabolize styrene into styrene oxide, which was not 
characterized in this work, the observed enhancement at 30 min reactions is lower 
than that at 10 min reactions (see Figure 4.12). 
4.3.2 UV-VIS SPECTROSCOPIC ANALYSIS 
It has been well established that UV-Vis spectra of cytochrome P450s is 
sensitive to the redox state of the heme as well as its local environment.33 OleT is in 
a low-spin ferric resting state with its heme iron axially coordinated by cysteine 
thiolate and a distal H2O molecule, which shows a maximum Soret band at 418 nm. 
Substrate binding displaces the axial water and converts the heme iron from low-
spin to a high-spin state with a maximum Soret band at 394 nm (Figure 4.11).16 
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Therefore, we can readily use UV-Vis spectroscopy to evaluate the interaction of 
small molecules with the OleT active site. As shown in Figure 4.12B, with addition 
of 2.5 mM of 3 to OleTSA (at the low-spin state), a shift of heme spectrum was 
observed, indicating a close proximity of 3 to the heme. Similar phenomenon was 
observed for the as-purified OleTSA treating with 3 (Figure 4.12C), while 3 has no 
specific absorbance above 300 nm wavelength (Figure 4.12D). These spectrum 
shifts suggest an interfering effect between heme and H2O/substrates. With addition 
of eicosanoic acid (C20 FA) followed by 3, the enzyme shifted from low-spin state 
to high-spin state, clearly demonstrating that the presence of 3 does not hinder the 
C20 FA binding to the enzyme active site. 
 
Figure 4.11 Scheme of the OleTSA catalytic cycle. OleTSA is in a ferric resting state 
with its heme iron coordinated by a H2O molecule. (i). Substrate binding displaces 
the axial water and converts the heme iron from low-spin to a high-spin state. (ii). 
H2O2 reacts with the high-spin enzyme to yield the reactive ferryl (FeIV)-oxo 
porphyrin radical cation (Cpd I, iii). Cpd I abstracts a hydrogen atom from the Cβ 
position, resulting in formation of a substrate radical and the ferryl (FeIV)-hydroxo 
species (Cpd II, iv), from which Cα–Cβ double bond forms, a CO2 eliminates and a 
terminal alkene releases. The simultaneous recruitment of a proton to the heme 
restores the resting state(i). 
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Figure 4.12 (A) Scheme of OleTSA catalyzed decarboxylation reactions with 
activator (top) and fatty acids coordinating to the active center with small molecule 
accessing (bottom). (B) UV-Vis spectrum of low-spin state of OleTSA (5 μM) 
binding with 3 (2.5 mM) and eicosanoic acid (5 μM). (C) UV-Vis spectrum of 
OleTSA as purified treated by 3 (5 mM) and (D) 3 only (5 mM). 
4.3.3 OLETSA ACTIVITY ANALYSIS IN THE PRESENCE OF SMALL MOLECULES 
To test the effect of 3 on OleTSA enzymatic activity, OleT catalyzed C20 FA 
reactions was done in the presence of different concentration of 3. Nonadecene, as 
the sole product of the reaction, was monitored. As shown in Figure 4.13A, with 
increasing concentration of 3 from 1 mM to 20 mM added, increasing production of 
nonadecene was obtained, indicating that 3 acted as an OleTSA enzyme activator in 
these reactions. Neither saturation nor inhibiting effect was observed, which implies 
that the small molecules do not hinder the C20 FA binding to the enzyme. A typical 
time course analysis of the reaction with C20 FA as substrate was shown in Figure 
4.13B. Interestingly, a burst of product release was observed at 5 min of reaction, 
and more than 2.5-fold nonadecene yield was obtained in the presence of 3. A similar 
113 
enhanced OleT activity was observed with stearic acid (C18 FA) and hydrocinnamic 
acid as substrates (Figure 4.13C, Figure 4.14). When the chain length of fatty acid 
got shorter, the enhancement of catalytic efficiency became less significant (e.g. 
49% of enhancement for palmitic acid (C16 FA) vs. 31% of enhancement for 
myristic acid (C14 FA) vs. < 7% of enhancement for lauric acid (C12 FA) (Figure 
4.13C, Figure 4.14). We believe that the varied conformation of the different chain 
length of fatty acids in the hydrophobic enzyme pocket may restrict the small 
molecule’s effect. Above data support our hypothesis that the small molecules get 
access to enzyme pocket and accelerate the catalysis by modifying heme local 
environment (Figure 4.11A). 
 
Figure 4.13 (A) OleTSA activity test in the presence of different concentration of 3. 
Reaction condition: 5 μM OleTSA, 1 mM C20 FA, 2 mM H2O2, 60 min at room 
temperature. (B) Time course study of nonadecene production in the presence or 
absence of 3. Reactions were performed with 1 mM C20 FA, 2 mM H2O2, with 20 
mM 3 or without 3 (as control). (C) Up to 3.5-fold enhanced OleT activity in the 
presence of 3 can be achieved depending on different substrates including C20 FA, 
C18 FA, C16 FA, C14 FA, C12 FA and hydrocinnamic acid (HA). Only 
corresponding terminal alkene production was recorded here. Reaction condition: 5 
μM OleTSA, 1 mM substrates. 2 mM H2O2. Note: C20 fatty acid was dissolved in 
70% ethanol/30% triton, all other substrate stocks were dissolved in DMSO. For the 
reactions with C20, C18, C16, C14 FA substrates, 20 mM small molecule was used; 
for reactions with C12 FA and HA substrate, 2 mM small molecule was used. Error 




Figure 4.14 Molecule 3 concentration dependence tests of OleTSA catalysis with 
C18 FA (A), C16 FA (B), C14 FA (C) and C12 FA (D). Corresponding alkene 
production was reported. Reaction condition: OleTSA 5 μM, fatty acid 0.5 mM, and 
2 mM H2O2, 150 μL reaction incubation RT for 60 minutes. 250 μM C16 alkene was 
used as internal standard. 300 μL CHCl3 extraction before GC. Error bars indicate 
the standard deviation of duplicate experiments (n = 2). 
While 3 displays significantly activating effect on OleT catalysis, a high 
working concentration is required. One possible reason for this limitation is because 
of its low potency to pass through the enzyme channel. To overcome this limitation, 
by mimicking the fatty acid structure, 4 was synthesized with a four-carbon ‘tail’ 
attached to the triazole group (Table 1, 4). We hypothesize that this molecule is 
easier to get into OleT enzyme active site, thus it can facilitate the catalysis by 
coordinating the heme structure and substrates. To avoid the potential blocking 
effect on fatty acids substrates due to the carbon tail of 4, hydrocinnamic acid (HA) 
and bromophenyl propionic acid (BA) were used as substrates to identify the effect 
of 4 on the enzyme activity. As shown in Figure 4.15A, in the presence of 1 mM of 
4, OleTSA displayed significant improved catalytic efficiency (5.5-fold enhancement 
for HA, 1.5-fold enhancement for BA relative to that in the absence of such small 
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molecules). Since HA binding does not introduce spin shift of OleT significantly, 
we used BA as a model to illustrate the binding spectra of OleTSA with 4. As shown 
in Figure 4.15B, by treating with 50 μM BA, the enzyme showed a significant low-
spin to high-spin switch. With the addition of 4 (the concentration increased from 
50 μM to 200 μM) followed by BA, further extent of spin shifts of OleTSA occurred 
demonstrating a cooperative-like binding of small molecule and substrate with OleT 
active site. Furthermore, in the presence of 2 mM 4, around 1-fold of decreased KD 
was obtained compared to that in the absence of small molecule (Figure 4.15C, D). 
Unexpectedly, we found that 4 could be hydroxylated by OleTSA with a slow 
reaction rate (Figure 4.16). Overall, these results confirm our hypothesis that the 
selected small molecules and substrates locate to the enzyme active site 
simultaneously as shown in Figure 4.11A. C20 FA metabolism was also tested in 
the presence of 4, no notable enhanced OleT activity was observed, which may be 
attributed to the blocking effect of these small molecules to the large fatty acids. or 
a different conformation of the more complicated van der Waals complex. Further 
investigation of the enzyme/small molecules complex structure will be helpful to 
understand the reasons. 
Another set of molecules including 5, 6, 7 (Table 4.1) were synthesized to 
further explore the potential OleT enzyme activators with HA as substrate. 5 can 
also serve as a potent OleT activator (e.g. > 100% enhancement of OleT activity on 
hydrocinnamic acid). While with a short ‘hydrophobic tail’ in 6, the enhanced effect 
was significant decreased. With one hydroxyl group added in the end of the tail of 
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7, the enhanced effect on the enzyme was totally abolished implying the importance 
of the nonpolar tails. 
 
Figure 4.15 (A) Molecule 4 increases OleT activity on hydrocinnamic acid (HA) and 
bromophenyl propionic acid (BA) as substrates. OleTSA (5 μM), 4 (1 mM), substrate (1 
mM), and H2O2 (2 mM) were incubated at room temperature for 10 min. The reactions 
without 4 were carried out as controls. Error bars indicate the standard deviation of 
duplicate experiments (n = 2). (B) BA (50 μM) and 4 demonstrate cooperativity in binding 
spectra. (C) UV-Vis binding titration of BA with OleT and the dissociation constant 
calculation. (D) UV-Vis binding titration of BA with OleT in the presence of 4 (200 μM) 
and the dissociation constant calculation.  
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Figure 4.16 (A) LC spectrum of metabolized 3 by OleTSA. Reaction condition: 0.5 mM 4, 
5 μM OleTSA, 2 mM H2O2, incubation at room temperature for 30 min. 1,2,3,4-tetrametyl 
benzene was used as standard. (B) Hydroxylated product was identified by mass 
spectrometry analysis (Top). The mass spectrometry analysis of Molecule 3 is shown 
(Bottom) Further characterization of the product is undergoing in our lab. 
4.3.4 THE ORIGINS OF THE OLETSA ACTIVITY ENHANCEMENT ANALYSIS 
The shift of heme spectrum of low-spin state enzyme (Figure 4.12B) caused by the 
small molecules suggesting that these small molecules could alter the heme/H2O local 
environment, from which the enzyme could be readily oxidized by H2O2 for its catalysis 
(Figure 4.1). It is possible that the reactivity between heme and H2O2 is altered by the small 
molecule, which facilitates the enzyme’s catalysis. The improved efficiency in this step 
further releases the oxidative stress caused by excess of H2O2. Both effects could contribute 
to the apparent enzymatic activity. To identify this possibility, a H2O2 titration assay was 
done in the presence and absence of 3. As shown in Figure 4.17A, the optimal 
concentration of H2O2 for OleTSA activity was 2 mM. With increasing concentration of 
H2O2, OleTSA showed decreased activity because of the oxidative toxicity of H2O2. Clearly 
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the enhanced effect of the small molecule was highly related to the H2O2 concentration. 
For example, when 0.2 mM H2O2 was used, only around 20% enhancement was obtained 
in the presence of 2 mM of 3. With increasing H2O2concentration up to 30 mM, 6 to 50-
fold enhancement was observed. It suggests that the toxicity of H2O2 to OleTSA enzyme 
can be dramatically inhibited by small molecules indicating an oxidative stress releasing 
involved mechanism. In Chapter 2, we utilized GOx and glucose to develop an in situ H2O2 
generating method to optimize the OleT catalytic efficiency by minimizing H2O2 toxicity. 
With this method, the small molecule dependent enhancement on the enzyme catalytic 
efficiency was diminished (Figure 4.17B) further supporting our hypothesis that the origin 
of the enhancement of small molecules is from enzyme oxidative step. 
 
Figure 4.17 (A) Molecule 3 stimulates OleT enzymatic activity in the presence of high 
H2O2 concentration. Reactions were performed with 5 μM OleTSA, 2 mM 3, 2 mM HA and 
different concentration of H2O2 for 1h reaction at room temperature. (B) The enhanced 
effect of 3 on OleT catalytic efficiency is diminished with an H2O2 in-situ release process 
(GOx method). One-time addition of H2O2 (2 mM) was used in H2O2 method. GOx (300 
nM) and glucose (6.6 mM) were used in GOx method. In all conditions, 5 μM OleTSA, 1 
mM HA, 1-hour reaction at room temperature were used in all conditions. Error bars 
indicate the standard deviation of duplicate experiments (n = 2). 
4.4 CONCLUSION 
In summary, we report to use small molecules to leverage P450 OleTSA 
enzymatic catalysis. Though only a small scale of molecules explored in this work, 
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up to 6-fold enhanced OleT enzymatic activity have been obtained. We found that 
the small molecules and enzyme substrates could reside in the enzyme active site 
simultaneously, and proposed the origins of the enhancement were from the enzyme 
oxidation step and an H2O2 toxicity inhibiting effect. Our work sheds the light to the 
application of small molecules to increase OleT catalytic efficiency, which could be 
potentially used for future olefin-production applications. However, further 
mechanistic investigation, especially on the enzyme-small molecule-substrate 
complex structure data, is necessary to better understand the system. It may also 
provide direct evidence and useful information for the design of next generation 
activators. 
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CHAPTER 5 
BIPHASIC CATALYSIS USING SURFACTANT ASSISTED ENZYME BASED 
INTERFACIAL ASSEMBLY FOR TERMINAL ALKENE PRODUCTION
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5.1 INTRODUCTION 
Organic-aqueous biphasic catalysis is an important process in chemical industry 
because it provides a way of heterogenizing the catalysts and substrates/products into two 
immiscible phases, which are ready for separation and purification.1,2 This process is 
particularly useful for enzyme based synthesis because enzymes prefer aqueous media like 
that in natural environment, while many substrates/products (e.g. lipids, fatty acids, 
alkenes) have limited solubility in water.3 The organic-aqueous biphasic catalysis represent 
a promising strategy to address these limitations. The slow mass transportation due to the 
small interfacial areas in the biphasic reactions will, however, significantly reduce the 
enzymatic reaction rates. A versatile method to address this problem is to create an 
emulsion (i.e. classical emulsion, Pickering emulsion) with aqueous phase containing 
catalysts and organic phase containing the substrates and /or products. 
A classical emulsion (as shown in Figure 5.1A) is to introduce surfactants or 
surface-active polymers (i.e. polymers with amphiphilic properties) to stabilize dispersions 
in aqueous or non-aqueous media.4 The hydrophile-lipophile balance (HLB) number, the 
packing parameter setting by geometry of the surfactant molecules, and the extent of 
hydration/solvation by separated phase are important variables in determining whether 
aggregated surfactant (micelles or emulsion droplets) resides in either water, oil, or a third 
phase.5 With selected surfactants and well-designed polymers, some examples of 
enzymatic reactions conducted in emulsions or reverse micelles as ‘nanoreactor’ have been 
reported.6–9 The increased interfacial area of different phases and improved stability of 
enzymes encapsulated in the emulsion droplets were attributed to the advanced catalytic 
efficiency. 
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Solid nano- or microparticles can function in similar ways as surfactants to form 
emulsions, which was firstly reported by Picking and Ramsden10 about a century ago and 
thus known as Pickering emulsions (Figure 5.1B). One key relevant parameter determining 
Pickering emulsion type is the contact angle (θ), which the particle makes with the interface 
determined by the partial wettability of the solid by different phases.5,11,12 Pickering 
emulsion does not require surfactants that often show adverse effects on enzymes’ 
functionality (for example through irritancy, hemolytic behavior), but retains the basic 
properties of classical emulsions. Pickering emulsions are usually much smaller than 
classical emulsions depending on the size of solid particles. Recently, increasing attentions 
have been given to use Pickering emulsion for enzymatic biphasic catalysis,13–16 which 
demonstrated superior catalytic efficiency compared to conventional biphasic reactions. 
Besides solid particles, we and others have established that bionanoparticles such as plant 
viruses, bacterial phages and ferritins can also be used for Pickering emulsions to generate 
droplets or nanoparticles through interfacial assembly.11,17,18 
 
Figure 5.1 Schematic illustration of classical (surfactant-based) emulsion (A) and a 
Pickering emulsion (B). Both represent oil-in-water type. 
Many proteins are surface-active molecules because of their amphiphilic nature 
which makes them a logic choice as emulsifiers/stabilizers of emulsions. In particular, 
some milk proteins (e.g. β-lactoglobulin and β-casein) have been widely used in food 
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emulsions.19 However, due to a dramatic change of the polarity in environment, many 
proteins could lose part of their tertiary structural features upon adsorption to the oil/water 
interface and generate considerable amounts of non-native secondary structures.20 Except 
of some special interface-activating enzymes (e.g. lipase),21 it is a challenge to employ 
functional proteins (e.g. enzymes) directly as the ‘emulsifier’ for emulsion formation. In 
our previous study, we utilized co-assembly strategy to generate polymer-protein core shell 
nanoparticles, in which enzymes, playing a surfactant-like role, adsorbed on the polymeric 
surface and stabilized the nanosturcutre.22,23 Some efforts have been placed to utilize the 
polymers to modulate enzymes’ surface properties in order to facilitate emulsions forming 
and maintain enzymes’ function in a harsh environment.15,24,25 
P450 OleTSA enzyme
26 catalyzes the conversion of fatty acids to terminal alkenes 
using hydrogen peroxide as a cofactor through a single step of decarboxylation. This 
process has attracted broad interests for the sustainable production of fuels that are 
compatible with the existing energy infrastructure.27–29 However, the practical application 
of this enzyme is hampered by its sluggish turnover rate primarily due to the oxidative 
damage of the heme prosthetic group by the excess H2O2 or the derivatized oxidative 
species.30 We tried to circumvent this oxidative side reaction by a glucose oxidase (GOx) 
enzyme based H2O2 in situ generating method, which has been described in Chapter 2. On 
the other hand, the low solubility of substrate, i.e. fatty acids, in water is another important 
factor limiting the synthetic application of this enzyme in conversional monophasic 
reactions. In this chapter, we explored a surfactant-assisted emulsion process to study 
OleTSA involved biphasic catalysis for fatty acid decarboxylation applications (Scheme 
5.1). 
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Surfactants are amphiphilic compounds that lower the interfacial tension between 
organic and aqueous phases which have been widely used as emulsifiers, foaming agents, 
and dispersants in industry and research.31 The decoration of surfactant on nanoparticles32 
and proteins33,34 modulates their surface wetting properties and thus trigger interfacial 
assembly to form emulsions. In this work, we screened a list of surfactants, and revealed 
that the interaction between sodium dodecyl sulfate (SDS) and OleTSA can significantly 
facilitate the emulsion droplet formation. We hypothesize that the SDS modified enzymes 
acting as surface-active particles absorb on the oil/water interface via interfacial assembly, 
a similar process to the formation of Pickering emulsion. 
In the biphasic catalytic reactions, fatty acids were dissolved in the oil phase. Equal 
amounts of SDS modify OleTSA and GOx enzyme were used to form emulsions, and D-
mannose was added to initiate the tandem catalysis. We found that in the emulsion based 
biphasic reactions, the production of terminal alkene is comparable to that in conventional 
enzymatic reactions in aqueous solution, and above 96% of alkene product was enriched 
in organic layer. Overall, this surfactant-assisted enzyme based emulsion system represents 
an efficient method for biphasic catalysis and could be applied for enzyme based synthesis. 
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Scheme 5.1 Schematic illustration of the of protein/surfactant complex formation, the self-
assembly of protein/surfactant complex to generate emulsions. 
5.2. EXPERIMENTAL DETAILS 
5.2.1. MATERIALS 
Eicosanoic acid (C20:0), stearic acid (C18:0), SDS and hexane were purchased 
from BDH Chemicals. Cetrimonium bromide (CTAB), dodecyltrimethylammonium 
bromide (DTAB), sodium Bis(2-ethylhexyl) sulfosuccinate (AOT), Trion X -100 and 1-
hexadecene was purchased from TCI chemicals. GOx from Aspergillus niger and H2O2 
were purchased from Sigma. D-Glucose was purchased from Fisher. All chemicals and 
solvents used were of analytical grade and were used as received from commercial sources. 
200 mM K2HPO4, 100 mM NaCl, pH 7.4 was used as buffer A unless otherwise noted. 
5.2.2. PROTEIN EXPRESSION AND PURIFICATION 
The protein expression and purification process is the same as described in Chapter 
2. Briefly, the kanamycin-resistant plasmid T5 containing a OleTSA-His6 gene was 
transformed BL21(DE3) containing the chloramphenicol-resistant pTF2 plasmid encoding 
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for GroEL/GroES/Tig chaperones. A modified Terrific Broth (TB) (24 g/L yeast extract, 
12 g/L tryptone, 4 g/L peptone) supplemented with 50 μg/mL kanamycin and 20 μg/mL 
chloramphenicol was used for culturing. 125 mg/L thiamine, and trace metals, 100 μM 
IPTG, 10 ng/mL tetracycline and 10 mg/L of 5-aminolevulinic acid were added for protein 
expression, which was done at 18 °C for 16-18 h.26 The protein was purified using nickel-
nitriloacetic acid (Ni-NTA) affinity chromatography followed by Butyl-S-Sepharose 
column polishing step. Fractions with an Rz value (Abs418 nm/Abs280 nm) above 1.2 
were pooled and dialyzed against 200 mM KPi pH 8. Proteins were stored at -80 °C until 
further use.26 
5.2.3. EMULSIONS GENERATION VIA INTERFACIAL ASSEMBLY 
The surfactants were dissolved in H2O (unless otherwise noted), then mixed with 
protein(s) solution, and incubated at room temperature for 10 min. Generally, the final 
concentration of surfactants used is lower than their critical micelle concentration (CMC, 
unless otherwise noted, see Table 5.1). Then equal volume of hexane was added into the 
above solution in a 1.5 mL tube. Shake the mixture by hand for several minutes to generate 
emulsions. For example, for SDS assisted enzyme emulsion formation, 150 μL of 6 mM 
SDS in H2O was mixed with 150 μL of 10 μM OleTSA in buffer A in a 1.5 mL tube and 
incubated for 10 minutes at room temperature before 300 μL hexane was added. The 
mixture was shaken gently for 1-3 minutes for emulsion formation. The emulsions were 
not purified for further characterization.  
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5.2.4 CHARACTERIZATION OF THE PROTEIN-SDS INTERACTION AND 
EMULSIONS 
Fluorescent spectrum of OleT enzyme solution in the presence and absence of 
surfactant was measured by Varian Eclipse fluorescence spectrophotometer. The zeta 
potential was measured with dynamic light scattering (DLS, Zetasizer Nano ZS, Malvern 
Instruments). UV-Visible spectroscopy on an HP 8453 spectrophotometer and a quartz 
cuvette with 1 cm path length were used for UV-Vis test. For confocal imaging, EGFP/SDS 
solution was used as aqueous phase, hexane was used as organic phase for emulsion 
generation, excited at 488 nm. An organic soluble dye Nile red was used to stain the oil 
phase of OleTSA/SDS emulsions. 
5.2.5 ENZYMATIC REACTION IN BIPHASIC CATALYSIS AND THE ACTIVITY 
TEST 
Aqueous solution (300 μL) including 5 μM OleTSA, 5 μM GOx and 0.3 mM SDS 
in buffer A was incubated at room temperature for 10 minutes in a 1.5 mL Eppendorf tube. 
Hexane (300 μL) with 4 mM eicosanoic acid was used as the organic solution, which was 
added into the above aqueous solution in the tube and shaken for several minutes. D-
Mannose was added to initiate the reaction (the final concentration was controlled at 7 
mM). After 60 minutes’ reaction, the emulsion phase and aqueous phase were separated 
into two 1.5 mL tubes. 10% HCL was added to quench the reactions. Then internal standard 
was added. For emulsion phase, centrifuge at 14000 g for 2 minutes to breakdown the oil 
drops and run the sample on GC. For aqueous phase, use the same volume of chloroform 
for extraction, run the chloroform layer on GC.  
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5.3. RESULT AND DISCUSSION 
5.3.1. SURFACTANT SELECTION 
Surfactants with opposite charge to proteins have been reported to interact with 
proteins through electrostatic interactions for interfacial assembly study.34 In this work, we 
expanded the selection range and included different types of surfactants in order to identify 
the suitable one interacting with the OleTSA to form emulsion efficiently while sustaining 
enzyme activity (Table 5.1). We found that both negative and positive charged surfactants 
could facilitate the OleTSA based emulsion formation, though the emulsion droplet size and 
stability could be varied depending on the charge, size and other properties of individual 
surfactant. Among them, SDS was chosen because the interaction between SDS and 
OleTSA significantly facilitated the emulsions’ formation and stabilization. 
5.3.2. OLETSA SDS INTERACTION CHARACTERIZATION 
The interaction between SDS and denatured proteins has been well established. For 
example, high concentration of SDS (e.g. 80 mM ) was used to coat denatured proteins and 
mask its intrinsic charge for SDS-PAGE analysis.35 We tested different concentration of 
SDS (Table 5.1) and figured out that 60:1 (e.g. 0.3 mM SDS and 5 μM OleT) was the 
optimal ratio to facilate the emulsion formation while with the enzyme activity susained. 
As shown in Figure 5.2A, the florscence spectrum of OleTSA did not change after SDS 
treating suggesting sustained enzyme conformation. An obvious heme spectrum shift was 
abserved with SDS treatment indicating that some SDS molecules entered into the enzyme 
active center interferring the spin state of heme (Figure 5.2B). However, this effect did not 
influence enzyme activity significantly (Figure 5.2C). Formation of the OleTSA/SDS 
complex was confirmed by the change of zeta potential from -7.5 to -10.3 after a SDS 
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treatment. Moreover, higher concentration of slat may interupt the enzyme/SDS interaction 
and interfer the complex formation (Figure 5.2D). This is consistent with our hypothesis 
that the negative charged SDS can interact with the positive residues on OleT surface, thus 
decreased its zeta potential. 
5.3.2. INTERFACIAL ASSEMBLY OF OLETSA-SDS TO FORM EMULSIONS AND 
ITS CHARACTERIZATION 
Hexane as oil phase and OleTSA/SDS dissolved in aqueous phase were used to 
generate microemulsions via interfacial assembly. As describe above, equal volume of 
hexane was added into Ole/SDS solution, with gentle shaking by hand, emulsions could be 
obtained. As controls, OleT enzyme only solution or SDS only solution, there was not 
obvious and stable emulsions formed (Figure 5.3A). These results further confirmed that 
the modification of OleT by SDS is key for a successful emulsion formation (likely due to 
the partial hydrophobilized effect). As shown in Figure 5.3B, the droplet size range of 
modified OleT/hexane emulsions was from ~50 – 300 μm. To visualize the type of 
emulsions, we applied water-immiscible Nile Red to stain the organic phase, in which red 
fluorescence only appeared in droplets indicating that oil-in-water (O/W) emulsions were 
formed (Figure 5.3C). In addition, we used EGFP protein solution to carry out a similar 
emulsion process in hexane. As expected, green emission was only observed in the 
continuous phase (Figure 5.3D). Based on above results, an oil-in-water (O/W) emulsion 
forming process via interfacial assembly was proposed and shown in Scheme 5.1.  
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Note: OleTSA (5 μM) as aqueous solution and hexane as organic phase were used for all 
tests. *CMC value is based on reported data at 25 °C in water.36,37 NA: Surfactant itself 
can form emulsion with hexane. So the effect of the surfactant cannot determined  
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Figure 5.2 (A) Fluorescence spectrum of OleTSA enzyme and SDS treated OleTSA enzyme 
excited at 280 nm. (B) UV-Vis spectrum of OleTSA and SDS treated OleTSA. (C) Activity 
comparison of OleT and SDS treated OleTSA. SDS treated OleTSA or free OleTSA (5 μM), 
eicosanoic acid (1 mM), GOx (5 μM), mannose (7 mM) were incubated at room 
temperature for 60 minutes. (D) Zeta potential test of OleT solution and SDS treated OleT 
solution with two different buffers. For ‘low salt’ sample: 100 mM K2HPO4, 50 mM NaCl, 
pH 7.4 was used for SDS/OleTSA incubation. For ‘high salt’ sample: 100 mM K2HPO4, 50 
mM NaCl, pH 7.4 was used for SDS/OleTSA incubation. For all SDS treated samples, SDS 
(0.3 mM) and OleT (5 μM) was incubated at room temperature for 10 minutes. 
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Figure 5.3 (A) Photographs of hexane/water Pickering emulsions. Shaking of SDS 
solution and hexane (1) or protein solution and hexane (3) do not form emulsions, while 
shaking of SDS/protein solution and hexane form emulsions easily. (B) Fluorescence 
microscopy images of EGFP/SDS stabilized Pickering emulsion with emission of 488 nm. 
(C) optical microscopy of OleTSA/SDS. (D) Fluorescence microscopy images of 
OleTSA/SDS stabilized Pickering emulsion with oil-soluble Nile red. Scale bars: 100 μm. 
5.3.3. BIPHASIC CATALYSIS USING OLET-SDS/HEXANE OIL-IN-WATER 
EMULSIONS 
OleT enzyme-based catalysis is hampered by the poor solubility of substrates (i.e. 
fatty acids) and products (i.e. terminal alkene). Furthermore, the inefficient product 
purification step (for example extraction) is also a major obstacle for its real synthetic 
application. Fortunately, both the fatty acids and terminal alkene products have high 
solubility in hexane and other organic solvents. Herein, we propose to use the emulsion 
based biphasic approach to optimize the OleT catalysis. In Chapter 2, we described a H2O2 
in situ generation method to improve OleT catalysis with coupling to GOx enzyme. Based 
on a similar process showing in Scheme 1, a multienzyme based oil-in-water emulsion 
process was carried out. 
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In this study, 4 mM eicosanoic acid (C20 FA) was dissolved in hexane as organic 
phase. An OleT-SDS and GOx-SDS enzyme mixture was used as aqueous phase. With 
following a gentle shaking by hand, the GOx-SDS/OleT-SDS droplets were formed 
(Figure 5.4A). D-mannose (7 mM) as GOx substrate was added to initiate the tandem 
catalysis. Nonadecene product was calculated in both oil and aqueous phase after the 
reaction. As shown in Figure 5.4B and 5.4C, we found that the produced alkene in the 
biphasic reaction was comparable to that in conventional one-phase enzymatic reactions, 
while above 96% of the product was enriched in organic phase showing unparalleled 
advantages. It is noteworthy that though the alkene production obtained in the biphasic 
reaction was similar to that in conventional enzymatic reaction, the enzyme at the water/oil 
interface displayed higher activity than that in control samples, because only the portion of 
enzymes absorbed at the interface contributed the fatty acids conversion, and the free 
enzymes could not catalyze the conversion due to the separation of substrate in oil phase 
and the free enzymes in aqueous phase.   
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Figure 5.4 (A) Scheme of OleTSA-SDS/GOX-SDS stabilized oil drops and the biphasic 
catalysis (top) and optical microscopy of OleTSA-SDS/GOX-SDS hexane droplet (bottom). 
Scale bar: 100 μm. (B) GC spectrum of nonadecene product distributed in organic and 
aqueous phase of the biphasic reaction. A conversional one-phase reaction was used as 
control. (C) Nonadecene product distribution calculation in the biphasic reactions and the 
control reaction. Reaction condition: for biphasic reaction, 5 μM of SDS treated OleT and 
5 μM SDS treated GOx, 4 mM eicosanoic acid dissolved in hexane, 7 mM mannose, 
incubation at room temperature for 60 minutes. For control reaction, the same condition as 
in the biphasic reaction above was used without hexane. 
5.4 CONCLUSION 
In summary, we have demonstrated a surfactant assisted enzyme based interfacial 
assembly system, in which the modified enzymes serving as ‘surface active’ particles were 
utilized to form oil-in-water emulsions. With this model, an efficient biphasic catalysis was 
carried out. The excellent catalytic efficiency of the emulsions was primarily attributed to 
the improved interfacial area compared to conventional biphasic reactions. More 
importantly, more than 96% of terminal alkene product was enriched in the organic phase 
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CHAPTER 6 
 FUTURE PERSPECTIVES 
In this dissertation, we demonstrate that protein(s) co-assembly can be a viable 
approach to manipulate and improve the multistep and multienzyme based catalysis via 
different mechanisms. More study to further understand the co-assembly process and its 
effects on enzyme catalysis will be beneficial to expand such strategy in enzyme 
engineering. In this chapter, we provide some perspectives on future works. 
In Chapter 1, we report that the products with different oxidation state can be 
enriched depending on the side groups of the substrates in CmlI catalyzed reactions, which 
makes this enzyme and polymer-enzyme NPs very useful in synthetic applications. Further 
investigations on a broad range of substrates of CmlI will be worth to try. In addition, co-
localization of CmlI with some non-natural protein redox partners via the polymer protein 
co-assembly will be an interesting direction to expand the polymer-multienzyme 
assembly’s applications in CmlI catalysis. 
For Chapter 2, the varied kinetics of GOx with different sugars provide useful tools 
to control H2O2 releasing process, which can be used to leverage the downstream OleTSA 
or other peroxygenases/peroxidase catalysis. OleTSA displays a relative broad H2O2-
responsive window and varied kinetics on different acids making it a unique model for 
GOx coupled tandem catalysis study. More detailed kinetics studies of both enzymes will 
provide useful information to understand the process and further optimize the enzyme 
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cascade catalysis. This information can also be used for simulation study to illustrate the 
proposed ‘channel-like’ effect on the polymer-multienzyme complexes. 
Also in this part of work, we clearly demonstrate that, with GOx coupling, heme 
bleaching of OleTSA can be mostly avoided during the catalysis. It will be promising to 
explore different recycling systems to maximize the reusability of these enzymes. 
Immobilization enzymes on inorganic nanoparticles or flow reactors can be used for such 
applications. In these processes, the substrate/O2 consumption, product inhibition and pH 
changing problems limiting the enzyme activity can be addressed. Importantly, the 
polymer-GOx/OleTSA NPs generated by co-assembly can be readily adapted in the flow 
reaction systems, providing excellent platform for biofuel production applications.  
Notably glucose is much cheaper than mannose and more accessible (e.g. from 
different bio-processes) in the practical synthesis, so it is worth to optimize the reaction 
conditions with glucose as the substrate (for example, by adjusting the ratio of GOx and 
OleT to co-assembly with different polymers). 
In Chapter 3, the pyridine-containing polymer protein co-assembly used here 
represents a unique multistep/multicomponent-involved assembly system. We 
demonstrated that the fast mixing imparted effects on the co-assembly process and 
increased the homogeneity of the resultant NPs, which is consistent with our hypothesis 
that the adsorption of proteins on polymer colloids (i.e. aggregation step) is the rate-
limiting step. More detailed descriptions about the process (e.g. aggregation timescale) are 
needed to further understand the co-assembly process. With this EK-based microfluidic 
system, the mixing process can be adjusted by electric field and flow rates. High-resolution 
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imaging system can be easily integrated. So it provides an excellent platform to further 
study and improve the polymer-protein(s) co-assembly process. 
In Chapter 4, we reported a novel phenomenon that small molecules could 
strikingly enhance OleTSA catalysis with changed kinetics. Structure data will be helpful to 
understand the origins of the enhancement. In addition, we found that the small molecules 
showed very different effects on different substrates including fatty acids and non-natural 
substrates. We observed less enhanced effect in the reactions with high turnover rate further 
supporting the H2O2 oxidative stress related mechanism. We speculate that some non-
natural substrates (e.g. 3-(4-methoxyyphennyl) propionic acid) themselves can serve as 
OleT activators based on their unparalleled turnover rates and the structure similarity to the 
small molecules we reported. Further study to illustrate these observations will be helpful 
to understand the enhanced effects. 
In Chapter 5, the preliminary data showed a promising GOx/OleT based biphasic 
catalytic system. Some important parameters and processes need to be characterized for 
further optimization in the future include:  
(1) The loading efficiency of OleT and GOx on the microemulsions. The different 
surface charge distribution of the two enzymes makes the interactions between enzymes 
and surfactants varied, which will cause different enzyme loading efficiency of the 
microemulsions.  
(2) The activity of OleT on the interface of microemulsions. As analyzed in Chapter 
5, we speculate that OleT enzyme activity can be greatly increased after the interfacial 
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assembly than that in aqueous solution. More direct evidence is needed to identify this 
possibility.  
(3) The activity of GOx on the microemulsions. We assume that GOx enzyme 
activity is not affected in the working concentration of surfactants used in this work, which 
need to be confirmed. 
(4) The interfacial assembly process. Different surfactants showed different effects 
on the microemulsions’ formation, stability and enzymatic activity suggesting complex 
interfacial assembly behaviors in the system. More in-depth investigations are needed to 
understand the assembly process.  
(5) Other microstructures formed in the multiphase system. While emulsions were 
observed in the enzyme/surfactants/hexane system, more study is needed to identify if any 
other micro- or nanostructures (e.g. micelles) were generated and contributed to the 
enzymatic activity.  
(6) Surfactant structures. Based on the further study, some rational designed 
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